Document:

Stock Purchase Agreement, dated November 14, 2005

 Exhibit 10.1 
  
 EXECUTION COPY 
  

  
 STOCK PURCHASE AGREEMENT 

 
 among 
  
 NYMEX HOLDINGS, INC., 
  
 GENERAL ATLANTIC PARTNERS 82, L.P., 
  
 GAPSTAR, LLC, 
  
 GAP COINVESTMENTS III, LLC, 
  
 GAP COINVESTMENTS IV, LLC 
  
 and

  
 GAPCO GMBH & CO. KG 
  
 Dated: November 14, 2005 
  

 TABLE OF CONTENTS 
  

					
	 	  	 	  	Page

	ARTICLE I DEFINITIONS	  	1
	 1.1
	  	Definitions	  	1
		
	ARTICLE II PURCHASE AND SALE OF PREFERRED STOCK	  	10
	 2.1
	  	Purchase and Sale of Preferred Stock	  	10
	 2.2
	  	New Certificate of Incorporation	  	11
	 2.3
	  	Use of Proceeds	  	11
	 2.4
	  	Closing	  	11
		
	ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE COMPANY	  	12
	 3.1
	  	Corporate Existence and Power	  	12
	 3.2
	  	Authorization; No Contravention	  	12
	 3.3
	  	Governmental Authorization; Third Party Consents	  	13
	 3.4
	  	Binding Effect	  	13
	 3.5
	  	Litigation	  	13
	 3.6
	  	Compliance with Laws	  	14
	 3.7
	  	Capitalization	  	14
	 3.8
	  	SEC Documents; Financial Statements	  	16
	 3.9
	  	Material Contracts	  	16
	 3.10
	  	No Material Adverse Change; Ordinary Course of Business	  	18
	 3.11
	  	Taxes	  	18
	 3.12
	  	Private Offering	  	19
	 3.13
	  	Labor Relations	  	19
	 3.14
	  	Employee Benefit Plans	  	19
	 3.15
	  	Liabilities	  	20
	 3.16
	  	Intellectual Property	  	20
	 3.17
	  	Privacy of Customer Information	  	22
	 3.18
	  	Potential Conflicts of Interest	  	23
	 3.19
	  	Outstanding Borrowing	  	23
	 3.20
	  	Environmental Matters	  	23
	 3.21
	  	Insurance	  	23
	 3.22
	  	Controls	  	24
	 3.23
	  	CFTC Regulatory Matters	  	24
	 3.24
	  	Stockholder Approval	  	25
	 3.25
	  	Proxy Statement	  	25
	 3.26
	  	Broker’s, Finder’s or Similar Fees	  	25
		
	ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS	  	25
	 4.1
	  	Existence and Power	  	25
	 4.2
	  	Authorization; No Contravention	  	26

  

 i 

					
	 	  	 	  	Page

	 4.3
	  	Governmental Authorization; Third Party Consents	  	26
	 4.4
	  	Binding Effect	  	26
	 4.5
	  	Purchase for Own Account	  	26
	 4.6
	  	Restricted Securities	  	27
	 4.7
	  	Broker’s, Finder’s or Similar Fees	  	27
	 4.8
	  	Accredited Investor	  	27
		
	ARTICLE V CONDITIONS TO THE OBLIGATION OF THE PURCHASERS TO CLOSE	  	27
	 5.1
	  	Representations and Warranties	  	27
	 5.2
	  	Compliance with this Agreement	  	28
	 5.3
	  	Officer’s Certificate	  	28
	 5.4
	  	Secretary’s Certificate	  	28
	 5.5
	  	Filing of Certificate of Merger	  	28
	 5.6
	  	Purchased Shares	  	28
	 5.7
	  	Investor Rights Agreement	  	28
	 5.8
	  	Registration Rights Agreement	  	29
	 5.9
	  	Stockholder Approval	  	29
	 5.10
	  	Opinion of Counsel	  	29
	 5.11
	  	No Material Adverse Change	  	29
	 5.12
	  	Consents and Approvals	  	29
	 5.13
	  	HSR Act	  	29
	 5.14
	  	No Material Judgment or Order	  	29
	 5.15
	  	Good Standing Certificates	  	29
	 5.16
	  	New Bylaws; Board of Directors	  	29
	 5.17
	  	Separation of Rights	  	30
	 5.18
	  	Closing Payment	  	30
		
	ARTICLE VI CONDITIONS TO THE OBLIGATION OF THE COMPANY TO CLOSE	  	30
	 6.1
	  	Representations and Warranties	  	30
	 6.2
	  	Compliance with this Agreement	  	30
	 6.3
	  	Officer’s Certificate	  	30
	 6.4
	  	Certificate	  	30
	 6.5
	  	Payment of the Purchase Price	  	31
	 6.6
	  	Investor Rights Agreement	  	31
	 6.7
	  	Registration Rights Agreement	  	31
	 6.8
	  	HSR Act	  	31
	 6.9
	  	Stockholder Approval	  	31
	 6.10
	  	Consents and Approvals	  	31
	 6.11
	  	No Material Judgment or Order	  	31
		
	ARTICLE VII INDEMNIFICATION	  	31
	 7.1
	  	Indemnification	  	31
	 7.2
	  	Notification	  	32
	 7.3
	  	Contribution	  	33
	 7.4
	  	Limits on Indemnification	  	33

  

 ii 

					
	 	  	 	  	Page

	 ARTICLE VIII AFFIRMATIVE COVENANTS
	  	34
	 8.1
	  	Conduct of Business of the Company	  	34
	 8.2
	  	Stockholder Approval	  	35
	 8.3
	  	No Solicitation	  	36
	 8.4
	  	Commercially Reasonable Efforts	  	37
	 8.5
	  	HSR Act and CFTC Approval	  	37
	 8.6
	  	Tax Reporting	  	38
	 8.7
	  	Inspection	  	38
	 8.8
	  	Litigation	  	39
	 8.9
	  	IRS Forms	  	39
	 8.10
	  	Intellectual Property	  	39
		
	 ARTICLE IX TERMINATION
	  	39
	 9.1
	  	Termination	  	39
	 9.2
	  	Survival	  	40
		
	 ARTICLE X MISCELLANEOUS
	  	41
	 10.1
	  	Survival of Representations, Warranties and Covenants	  	41
	 10.2
	  	Notices	  	41
	 10.3
	  	Successors and Assigns; Third Party Beneficiaries	  	42
	 10.4
	  	Amendment and Waiver	  	42
	 10.5
	  	Counterparts	  	43
	 10.6
	  	Headings	  	43
	 10.7
	  	Specific Performance	  	43
	 10.8
	  	GOVERNING LAW; CONSENT TO EXCLUSIVE JURISDICTION	  	43
	 10.9
	  	WAIVER OF JURY TRIAL	  	43
	 10.10
	  	Severability	  	44
	 10.11
	  	Rules of Construction	  	44
	 10.12
	  	Entire Agreement	  	44
	 10.13
	  	Fees	  	44
	 10.14
	  	Publicity; Confidentiality	  	44
	 10.15
	  	Further Assurances	  	45

  

 iii 

 EXHIBITS 
  

			
	 A
	 	Form of New Certificate of Incorporation
	 B
	 	Form of New Bylaws
	 C
	 	Existing Bylaws
	 D
	 	Existing Certificate of Incorporation
	 E
	 	Form of Investor Rights Agreement
	 F
	 	Form of Registration Rights Agreement
	 G
	 	Form of Skadden, Arps, Slate, Meagher & Flom LLP Opinion
	 H
	 	Form of Agreement and Plan of Merger
	 I
	 	Form of Certificate of Merger
	 J
	 	Form of Exchange Certificate of Incorporation
	 K
	 	Form of Exchange Bylaws

  
 SCHEDULES 
  

			
	 3.1
	 	Due Qualification
	 3.2
	 	Execution, Delivery and Performance
	 3.3(iii)
	 	CFTC Consents
	 3.3(vi)
	 	Authorizations and Consents
	 3.5
	 	Litigation
	 3.6(a)
	 	Compliance with Laws
	 3.6(b)
	 	Permits
	 3.7(a)
	 	Options, Warrants, Conversion Privileges, Subscription or Purchase Rights
	 3.7(b)
	 	List of Subsidiaries and their Equity Holders
	 3.9(a)
	 	Material Contracts
	 3.9(c)
	 	Contracts with Restrictive Covenants
	 3.10(b)
	 	Material Transactions
	 3.10(c)
	 	Compensation
	 3.11
	 	Taxes
	 3.14
	 	Employee Benefit Plans
	 3.14(d)
	 	Retiree Welfare Plans
	 3.16(a)(ii)
	 	Intellectual Property Owned by the Company and Filings and Applications Therefor
	 3.16(a)(iii)
	 	Intellectual Property Licenses, Sublicenses, Distributor Agreements and Other Agreements
	 3.16(a)(iv)
	 	Infringements by the Company of Intellectual Property of Others
	 3.16(a)(v)
	 	Intellectual Property Litigation
	 3.16(b)
	 	Infringements of Intellectual Property of the Company
	 3.16(e)(i)
	 	Intellectual Property Owned by Affiliates of the Company
	 3.16(e)(ii)
	 	Contributors to Intellectual Property Operating Under Grants
	 3.17
	 	Privacy Policy
	 3.18
	 	Potential Conflicts of Interest
	 3.19
	 	Outstanding Borrowing
	 3.21
	 	Insurance
	 3.23
	 	CFTC Regulatory Matters
	 3.26
	 	Brokers, Finder’s or Similar Fees
	 5.12
	 	Company Consents and Approvals
	 6.10
	 	Purchaser Consents and Approvals

  

 iv 

 STOCK PURCHASE AGREEMENT 
  
 STOCK PURCHASE AGREEMENT, dated as of November 14, 2005, by and among NYMEX HOLDINGS, INC., a Delaware corporation (the
“Company”), GENERAL ATLANTIC PARTNERS 82, L.P., a Delaware limited partnership (“GAP LP”), GAPSTAR, LLC, a Delaware limited liability company (“GapStar”), GAP COINVESTMENTS III, LLC, a
Delaware limited liability company (“GAP Coinvestments III”), GAP COINVESTMENTS IV, LLC, a Delaware limited liability company (“GAP Coinvestments IV”), and GAPCO GMBH & CO. KG, a German limited
partnership (“GmbH Coinvestment” and, collectively with GAP LP, GapStar, GAP Coinvestments III and GAP Coinvestments IV, the “Purchasers”). 
  
 WHEREAS, upon the terms and conditions set forth in this Agreement, the Company, immediately following the NYMEX Merger,
proposes to issue and sell to the Purchasers an aggregate of 8,160,000 shares of Series A Cumulative Redeemable Convertible Preferred Stock, par value $0.01 per share (the “Preferred Stock”), of the Company for $135,000,000.

  
 NOW, THEREFORE, in consideration of the mutual covenants and
agreements set forth herein, the parties hereto agree as follows: 
  
 ARTICLE I 
  
 DEFINITIONS 
  
 1.1 Definitions. As used in this Agreement the following terms have
the meanings indicated: 
  
 “Affiliate” shall
mean any Person who is an “affiliate” as defined in Rule 12b-2 of the General Rules and Regulations under the Exchange Act. 
  
 “Agreement” means this Agreement as the same may be amended, supplemented or modified in accordance with the terms hereof. 
  
 “Agreement and Plan of Merger” means the agreement and plan
of merger to be entered into by the Company and Merger Sub to effect the NYMEX Merger prior to the Closing, in the form attached hereto as Exhibit H. 
  
 “Alternative Proposal” shall mean (a) any offer or proposal, or any indication of interest in making an offer or proposal, made by
any “person” or “group” (as such terms are used for purposes of Section 13(d)(3) of the Exchange Act) at any time (i) which is structured to permit such person or group to acquire beneficial ownership of at least five
percent (5%) of the assets of the Company and its Subsidiaries taken as a whole, or at least five percent (5%) of the outstanding capital stock of the Company pursuant to a merger, consolidation, tender offer or other business combination,
sale or purchase of capital stock or Stock Equivalents, sale of assets, tender offer or exchange 

 
offer or similar transaction or (ii) which involves the incurrence or assumption of Indebtedness by the Company or any of its Subsidiaries on a secured
or unsecured basis of at least $5,000,000, including, in the case of clauses (i) and (ii) above, any single or multi-step transaction or series of related transactions, in each case other than the transactions with the Purchasers and
(b) any offer or proposal made in the context of a proxy contest with respect to clause (i) above. 
  
 “Antitrust Laws” means the HSR Act, the Sherman Act, as amended, the Clayton Act, as amended, the Federal Trade Commission Act, as
amended, and any other United States federal or state or foreign statutes, rules, regulations, orders, decrees, administrative or judicial doctrines or other laws that are designed to prohibit, restrict or regulate actions having the purpose or
effect of monopolization or restraint of trade. 
  
 “Basket” has the meaning set forth in Section 7.4 of this Agreement. 
  
 “Basket Exclusions” has the meaning set forth in Section 7.4 of this Agreement. 
  
 “Board of Directors” means the Board of Directors of the
Company. 
  
 “Business Day” means any day other
than a Saturday, Sunday or other day on which commercial banks in the State of New York are authorized or required by law or executive order to close. 
  
 “CEA” means the Commodity Exchange Act and the rules and regulations promulgated by the CFTC thereunder. 
  
 “Certificate of Merger” means the certificate of merger duly
filed with the Secretary of State of the State of Delaware to accomplish the NYMEX Merger, in the form attached hereto as Exhibit I. 
  
 “CFTC” means the Commodity Futures Trading Commission. 
  
 “Change of Control Transaction” means, with respect to the Company, (i) the direct or indirect sale,
transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of the properties or assets of the Company and its Subsidiaries, taken as a whole, to
any “person” or “group” (as such terms are used for purposes of Section 13(d)(3) of the Exchange Act) or (ii) the consummation of any transaction (including, without limitation, any merger or consolidation, or
other business combination) the result of which is that stockholders of the Company immediately prior to the consummation thereof would own less than 45% of the Common Stock of the Company or the common stock of the resulting company in such
transaction; provided that, in no event shall a Change of Control Transaction include any sale or other issuances of capital stock by the Company that is a minority investment in the Company by private equity firms, hedge funds,
venture capital firms or other similar pooled 

  

 2 

 
investment vehicles or any private equity or private investment division of any investment bank or commercial bank. 
  
 “Claims” has the meaning set forth in Section 3.5 of
this Agreement. 
  
 “Closing” has the meaning set
forth in Section 2.4 of this Agreement. 
  
 “Closing
Date” has the meaning set forth in Section 2.4 of this Agreement. 
  
 “Code” means the Internal Revenue Code of 1986, as amended, or any successor statute thereto. 
  
 “COMEX” means Commodity Exchange, Inc., a New York not-for-profit corporation. 
  
 “Commission” means the United States Securities and Exchange
Commission or any similar agency then having jurisdiction to enforce the Securities Act. 
  
 “Commodities Laws” shall mean all applicable filing, reporting and other provisions of the CEA, all applicable orders, approvals and interpretations of the CFTC and the National Futures Association
and all undertakings in connection with any investigation or examination by the CFTC or the National Futures Association. 
  
 “Common Stock” means the common stock, par value $0.01 per share, of the Company and, from and after the NYMEX Merger, shall include the
Restricted Common Stock and the Unrestricted Common Stock. 
  
 “Commonly Controlled Entity” means any entity which is under common control with the Company within the meaning of Section 414(b), (c), (m), (o) or (t) of the Code. 
  
 “Company” has the meaning set forth in the preamble to this
Agreement. 
  
 “Company Plan” has the meaning set
forth in Section 3.14 of this Agreement. 
  
 “Condition of the Company” means the assets, business, properties, operations or condition (financial or otherwise) of the Company and its Subsidiaries, taken as a whole. 
  
 “Confidentiality Agreement” means that certain
Non-Disclosure Agreement, dated as of July 12, 2005, by and between the Exchange and General Atlantic Service Corporation. 
  
 “Contingent Obligation” means, as applied to any Person, any direct or indirect liability of that Person with respect to any
Indebtedness, lease, dividend, guaranty, letter of credit or other obligation, contractual or otherwise (the “primary obligation”) of another Person (the “primary obligor”), whether or not contingent, (a) to

  

 3 

 
purchase, repurchase or otherwise acquire such primary obligations or any property constituting direct or indirect security therefor, (b) to advance or
provide funds (i) for the payment or discharge of any such primary obligation, or (ii) to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency or any balance sheet item, level
of income or financial condition of the primary obligor, or (c) to purchase property, securities or services primarily for the purpose of assuring the owner of any such primary obligation of the ability of the primary obligor to make payment of
such primary obligation. The amount of any Contingent Obligation shall be deemed to be an amount equal to the stated or determinable amount of the primary obligation in respect of which such Contingent Obligation is made or, if not stated or
determinable, the maximum reasonably anticipated liability in respect thereof. 
  
 “Contractual Obligation” means, as to any Person, any provision of any security issued by such Person or of any agreement, undertaking, contract, indenture, mortgage, deed of trust or other instrument
to which such Person is a party or by which it or any of its property is bound. 
  
 “Copyrights” means any foreign or United States copyright registrations and applications for registration thereof, and any non-registered copyrights. 
  
 “Customer Information” has the meaning set forth in
Section 3.17 of this Agreement. 
  
 “DOJ”
has the meaning set forth in Section 8.5 of this Agreement. 
  
 “Dubai” means, collectively, DME Holdings Limited, a limited company incorporated under the laws of Bermuda, and its sole Subsidiary the Dubai Mercantile Exchange (DME) Limited, a limited liability company formed under the
laws of the Dubai International Financial Centre, United Arab Emirates. 
  
 “Environmental Laws” means federal, state, local and foreign laws, principles of common laws, civil laws, regulations, and codes, as well as orders, decrees, judgments or injunctions, issued, promulgated, approved or
entered thereunder relating to pollution, protection of the environment or public health. 
  
 “ERISA” means the Employee Retirement Income Security Act of 1974, as amended. 
  
 “Excess Dividend Amount” has the meaning set forth in Section 2.4 of this Agreement. 
  
 “Exchange” means the New York Mercantile Exchange,
Inc., a Delaware non-stock corporation. 
  
 “Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder. 
  

 4 

 “Exchange Bylaws” means the Amended and Restated Bylaws of the Exchange adopted by the
board of directors of the Exchange and adopted by the members of the Exchange, in the form attached hereto as Exhibit K. 
  
 “Exchange Certificate of Incorporation” means the Amended and Restated Certificate of Incorporation of the Exchange approved by the board
of directors of the Exchange, adopted by the members of the Exchange and duly filed with the Secretary of State of the State of Delaware, in the form attached hereto as Exhibit J. 
  
 “Exchanges” means the Exchange and the COMEX. 
  
 “Existing Bylaws” means the Bylaws of the Company in effect
on the date hereof and attached hereto as Exhibit C. 
  
 “Existing Certificate of Incorporation” means the Amended and Restated Certificate of Incorporation of the Company, as amended, in effect on the date hereof and attached hereto as Exhibit D. 
  
 “Financial Statements” has the meaning set forth in
Section 3.8 of this Agreement. 
  
 “FTC” has
the meaning set forth in Section 8.5 of this Agreement. 
  
 “Fundamental Actions” has the meaning set forth in Section 3.24 of this Agreement. 
  
 “GA LLC” means General Atlantic LLC, a Delaware limited liability company and the general partner of GAP LP and the sole member of
GapStar, and any successor to such entity. 
  
 “GAAP” means United States generally accepted accounting principles in effect from time to time. 
  
 “GAP Coinvestments III” has the meaning set forth in the preamble to this Agreement. 
  
 “GAP Coinvestments IV” has the meaning set forth in the
preamble to this Agreement. 
  
 “GAP LP” has the
meaning set forth in the preamble to this Agreement. 
  
 “GapStar” has the meaning set forth in the preamble to this Agreement. 
  
 “GmbH Coinvestment” has the meaning set forth in the preamble to this Agreement. 
  

 5 

 “GmbH Management” means GAPCO Management GmbH, a German company with limited liability
and the general partner of GmbH Coinvestment, and any successor to such entity. 
  
 “Governmental Authority” means the government of any nation, state, city, locality or other political subdivision thereof, any entity exercising executive, legislative, judicial, regulatory or
administrative functions of or pertaining to government, including, without limitation, the CFTC and any corporation or other entity owned or controlled, through stock or capital ownership or otherwise, by any of the foregoing. 
  
 “HSR Act” has the meaning set forth in Section 3.3 of
this Agreement. 
  
 “Indebtedness” means, as to
any Person, (a) all obligations of such Person for borrowed money (including, without limitation, reimbursement and all other obligations with respect to surety bonds, letters of credit and bankers’ acceptances, whether or not matured),
(b) all obligations of such Person to pay the deferred purchase price of property or services, except trade accounts payable and accrued commercial or trade liabilities arising in the ordinary course of business, (c) all interest rate and
currency swaps, caps, collars and similar agreements or hedging devices under which payments are obligated to be made by such Person, whether periodically or upon the happening of a contingency, (d) all indebtedness created or arising under any
conditional sale or other title retention agreement with respect to property acquired by such Person (even though the rights and remedies of the seller or lender under such agreement in the event of default are limited to repossession or sale of
such property), (e) all obligations of such Person under leases which have been or should be, in accordance with GAAP, recorded as capital leases, (f) all indebtedness secured by any Lien (other than Liens in favor of lessors under leases
other than leases included in clause (e)) on any property or asset owned or held by that Person regardless of whether the indebtedness secured thereby shall have been assumed by that Person or is non-recourse to the credit of that Person, and
(g) any Contingent Obligation of such Person. 
  
 “Indemnified Party” has the meaning set forth in Section 7.1 of this Agreement. 
  
 “Indemnifying Party” has the meaning set forth in Section 7.1 of this Agreement. 
  
 “Intellectual Property” has the meaning set forth in
Section 3.16 of this Agreement. 
  
 “Internet
Assets” means any Internet domain names and other computer user identifiers and any rights in and to sites on the worldwide web, including rights in and to any text, graphics, audio and video files and html or other code incorporated in
such sites. 
  

 6 

 “Investor Rights Agreement” means the Investor Rights Agreement in the form attached
hereto as Exhibit E. 
  
 “Knowledge of the
Company” means the actual knowledge of Mitchell Steinhause, Richard M. Schaeffer, James E. Newsome, Christopher Bowen, Richard Kerschner, Kenneth D. Shifrin, Joe Raia, Samuel H. Gaer, Sean Keating, Thomas F. LaSala, Madeline J. Boyd or
Robert Levin; provided that, when “Knowledge of the Company” is utilized in this Article I in the definition of “Subsidiaries” with respect to London and Dubai, it shall be deemed to mean the knowledge of such
persons after reasonable inquiry. 
  
 “Liabilities” has the meaning set forth in Section 3.15 of this Agreement. 
  
 “Lien” means any mortgage, deed of trust, pledge, hypothecation, assignment, encumbrance, lien (statutory or other) or preference,
priority, security interest of any kind or nature whatsoever (excluding preferred stock and equity related preferences). 
  
 “London” means, collectively, NYMEX Europe Exchange Holdings Limited, a private limited company incorporated under the laws of England
and Wales, and its sole Subsidiary NYMEX Europe Limited, a limited liability company incorporated under the laws of England and Wales. 
  
 “Losses” has the meaning set forth in Section 7.1 of this Agreement. 
  
 “Material Contract” has the meaning set forth in Section 3.9 of this Agreement. 
  
 “Merger Sub” means NYMEX Merger Sub, Inc., a Delaware
corporation and a wholly owned Subsidiary of the Company. 
  
 “New Bylaws” means the amended and restated bylaws of the Company adopted by the Board of Directors, in the form attached hereto as Exhibit B. 
  
 “New Certificate of Incorporation” means the Amended and Restated Certificate of Incorporation of the
Company which, as a result of the NYMEX Merger, shall be the certificate of incorporation of the Company as of the Closing, in the form attached hereto as Exhibit A. 
  
 “NYMEX Merger” means the merger of Merger Sub and the Company, pursuant to the Agreement and Plan of Merger
and the Certificate of Merger, as a result of which (i) the New Certificate of Incorporation shall be the certificate of incorporation of the surviving corporation and (ii) the New Bylaws shall be the bylaws of the surviving corporation.

  
 “Orders” has the meaning set forth in
Section 3.2 of this Agreement. 
  

 7 

 “Patents” means any foreign or United States patents and patent applications, including
any divisions, continuations, continuations-in-part, substitutions or reissues thereof, whether or not patents are issued on such applications and whether or not such applications are modified, withdrawn or resubmitted. 
  
 “Permits” has the meaning set forth in Section 3.6(b)
of this Agreement. 
  
 “Person” means any
individual, firm, corporation, partnership, trust, incorporated or unincorporated association, joint venture, joint stock company, limited liability company, Governmental Authority or other entity of any kind, and shall include any successor (by
merger or otherwise) of such entity. 
  
 “Plan”
means any employee benefit plan, arrangement, policy, program, agreement or commitment (whether or not an employee plan within the meaning of section 3(3) of ERISA), including, without limitation, any employment or deferred compensation
agreement, executive compensation, bonus, incentive, pension, profit-sharing, savings, retirement, stock option, stock purchase or severance pay plan, any life, health, disability or accident insurance plan, whether oral or written, whether or not
subject to ERISA, as to which the Company or any Commonly Controlled Entity has any direct or indirect, actual or contingent liability. 
  
 “Preferred Stock” has the meaning set forth in the recitals to this Agreement. 
  
 “Privacy Policy” has the meaning set forth in
Section 3.17 of this Agreement. 
  
 “Proxy
Statement” has the meaning set forth in Section 3.25 of this Agreement. 
  
 “Purchased Shares” has the meaning set forth in Section 2.1 of this Agreement. 
  
 “Purchasers” has the meaning set forth in the preamble to this Agreement. 
  
 “Registration Rights Agreement” means the Registration Rights Agreement in the form attached hereto as
Exhibit F. 
  
 “Restricted Common
Stock” means, collectively, the Series A-1 Common Stock, the Series A-2 Common Stock and the Series A-3 Common Stock. 
  
 “Requirements of Law” means, as to any Person, any law, statute, treaty, rule, regulation, right, privilege, qualification, license or
franchise or determination of an arbitrator or a court or other Governmental Authority or stock exchange, in each case applicable or binding upon such Person or any of its property or to which such Person or any of its property is subject or
pertaining to any or all of the transactions contemplated or referred to herein. 
  

 8 

 “Retiree Welfare Plan” means any welfare plan (as defined in Section 3(1) of ERISA)
that provides benefits to current or former employees beyond their retirement or other termination of service (other than severance benefits, coverage mandated by Section 4980A of the Code, commonly referred to as “COBRA,” or benefits
the cost of which is fully paid by the current or former employee or his or her dependents). 
  
 “SEC Documents” has the meaning set forth in Section 3.8 of this Agreement. 
  
 “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder. 
  
 “Series A-1 Common Stock” means the Common Stock designated
as Series A-1 Common Stock in the New Certificate of Incorporation. 
  
 “Series A-2 Common Stock” means the Common Stock designated as Series A-2 Common Stock in the New Certificate of Incorporation. 
  
 “Series A-3 Common Stock” means the Common Stock designated as Series A-3 Common Stock in the New Certificate of Incorporation.

  
 “Special Payment” has the meaning set forth
in Section 2.4 of this Agreement. 
  
 “Software” means any computer software programs, source code, object code, data and documentation, including, without limitation, any computer software programs that incorporate and run the Company’s pricing models,
formulae and algorithms. 
  
 “SOX” has the
meaning set forth in Section 3.22 of this Agreement. 
  
 “Stock Equivalents” means any security or obligation which is by its terms, whether directly or indirectly, convertible into or exchangeable or exercisable for shares of Common Stock or other capital stock of the Company,
and any option, warrant or other subscription or purchase right with respect to Common Stock or such other capital stock. 
  
 “Stockholder Approval” means the approvals by the Company’s stockholders and the members of the Exchange, as applicable, of the
Fundamental Actions. 
  
 “Stockholders’
Meeting” has the meaning set forth in Section 8.2(b) of this Agreement. 
  
 “Subsidiaries” means, as of the relevant date of determination, with respect to any Person, a corporation or other Person of which 50% or more of the voting power of the outstanding voting equity
securities or 50% or more of the outstanding economic equity interest is held, directly or indirectly, by such Person. Unless otherwise 

  

 9 

 
qualified, or the context otherwise requires, all references to a “Subsidiary” or to “Subsidiaries” in this Agreement shall refer to a
Subsidiary or Subsidiaries of the Company. In addition, (i) the Exchanges are Subsidiaries of the Company, and (ii) London and Dubai shall be deemed Subsidiaries solely for purposes of Sections 3.1, 3.5, 3.6, 3.7(b), 3.9, 3.10, 3.11,
3.15, 3.16(a)(i), 3.16(a)(iv), 3.23, 8.1 and 8.7; provided that (x) the representations and warranties made in Sections 3.1, the first sentence of Section 3.5, 3.9, 3.10, 3.11, 3.15, 3.16(a)(i) and 3.16(a)(iv), to the extent that
they relate to London or Dubai, shall be deemed to be made to the Knowledge of the Company and (y) the covenants made in Sections 8.1 and 8.7 shall apply to London or Dubai only to the extent that such items are within the Company’s
reasonable control. London and Dubai shall not be deemed Subsidiaries for any other purpose in this Agreement. 
  
 “Taxes” means any federal, state, provincial, county, local, foreign and other taxes (including, without limitation, income, profits,
windfall profits, alternative, minimum, accumulated earnings, personal holding company, capital stock, premium, estimated, excise, sales, use, occupancy, gross receipts, franchise, ad valorem, severance, capital levy, production, transfer,
withholding, employment, unemployment compensation, payroll and property taxes, import duties and other governmental charges and assessments), whether or not measured in whole or in part by net income, and including deficiencies, interest, additions
to tax or interest, and penalties with respect thereto. 
  
 “Trade Secrets” means any trade secrets, research records, processes, procedures, manufacturing formulae, technical know-how, technology, blue prints, designs, plans, inventions (whether patentable and whether reduced to
practice), invention disclosures and improvements thereto. 
  
 “Trademarks” means any foreign or United States trademarks, service marks, trade dress, trade names, brand names, designs and logos, corporate names, product or service identifiers, whether registered or unregistered, and
all registrations and applications for registration thereof. 
  
 “Trading Rights” has the meaning set forth in Section 5.17 of this Agreement. 
  
 “Transaction Documents” means, collectively, this Agreement, the Investor Rights Agreement and the Registration Rights Agreement.

  
 “Unrestricted Common Stock” means all shares
of Common Stock other than the Restricted Common Stock. 
  
 ARTICLE
II 
  
 PURCHASE AND SALE OF PREFERRED STOCK 
  
 2.1 Purchase and Sale of Preferred Stock. Subject to the terms and
conditions herein set forth, the Company agrees to issue and sell to the Purchasers, and 

  

 10 

 
the Purchasers, jointly and severally, agree to purchase from the Company, on the Closing Date, an aggregate of 8,160,000 shares of Preferred Stock (all of
the shares of Preferred Stock being purchased pursuant hereto being referred to herein as the “Purchased Shares”), for $135,000,000. The Purchasers shall deliver to the Company, at least two Business Days prior to the Closing, a
notice which shall specify the number of Purchased Shares to be purchased by each Purchaser pursuant to this Section 2.1; provided that, such allocation shall not modify the joint and several obligation of the Purchasers to
acquire all of the Purchased Shares. 
  
 2.2 New Certificate of
Incorporation. The Purchased Shares shall have the preferences and rights set forth in the New Certificate of Incorporation. 
  
 2.3 Use of Proceeds. The Company shall use the proceeds from the sale of the Purchased Shares to the Purchasers to make a special distribution to
stockholders of record of the Company as of the close of business on the Business Day immediately prior to the Closing Date (which shall not include the Purchasers). 
  
 2.4 Closing. Unless this Agreement shall have terminated pursuant to Article IX, and subject to the satisfaction
or waiver of the conditions set forth in Articles V and VI, the closing of the sale and purchase of the Purchased Shares (the “Closing”) shall take place at the offices of Paul, Weiss, Rifkind, Wharton & Garrison LLP,
1285 Avenue of the Americas, New York, New York, at 10:00 a.m., local time, on the second (2nd) Business Day following the date upon which the conditions set forth in Articles V and VI shall be satisfied or waived in accordance
with this Agreement, or at such other time, place and date that the Company and the Purchasers may agree in writing (the “Closing Date”). On the Closing Date, the Company shall deliver to each Purchaser (x) a certificate
or certificates in definitive form and registered in the name of each such Purchaser, representing its Purchased Shares against delivery by each of the Purchasers to the Company of the aggregate purchase price therefor by wire transfer of
immediately available funds, and (y) in the event that at any time after the date hereof but prior to the Closing Date the Company establishes a record date for the payment of or pays any dividend or other distribution to its existing
stockholders in accordance with Section 8.1(h) of this Agreement in an aggregate amount in excess of $5,000,000 (the amount of such excess being referred to herein as the “Excess Dividend Amount”), a wire transfer of
immediately available funds in an amount (the “Special Payment”) equal to such Purchaser’s proportionate share of the product of (i) the Excess Dividend Amount multiplied by (ii) the quotient of 0.10 divided by 0.90.

  

 11 

 ARTICLE III  
  
 REPRESENTATIONS AND WARRANTIES OF THE COMPANY 
  
 The Company represents and warrants to each of the Purchasers as follows: 
  
 3.1 Corporate Existence and Power. Each of the Company and its
Subsidiaries (a) is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation, (b) has all requisite corporate power and authority to own and operate its property, to lease
the property it operates as lessee and to conduct the business in which it is currently engaged and (c) is duly qualified as a foreign corporation and in good standing under the laws of each jurisdiction in which its ownership, lease or
operation of property or the conduct of its business requires such qualification, except where the failure to be so qualified would not reasonably be expected to have a material adverse effect on the Condition of the Company. The Company has
the corporate power and authority to execute, deliver and perform its obligations under this Agreement and each of the other Transaction Documents to which it is a party. No jurisdiction, other than those in which it is duly qualified, has claimed
in writing that either the Company or any of its Subsidiaries, as the case may be, is required to qualify as a foreign corporation or other entity therein, and except as set forth on Schedule 3.1, neither the Company nor any of its
Subsidiaries files any franchise, income or other tax returns in any other jurisdiction based upon the ownership or use of property therein or the derivation of income therefrom. 
  
 3.2 Authorization; No Contravention. The execution, delivery and performance by the Company of this Agreement and
each of the other Transaction Documents to which it is a party and the transactions contemplated hereby and thereby and the approval and adoption of the New Certificate of Incorporation and the New Bylaws (a) except for receipt of Stockholder
Approval, have been duly authorized by all necessary corporate action of the Company (including the approval of the Board of Directors) or the Exchange (including the approval of the Board of Directors of the Exchange), as applicable,
(b) except for receipt of Stockholder Approval, do not contravene the terms of the Existing Certificate of Incorporation, the Existing Bylaws, the New Certificate of Incorporation, the New Bylaws or the certificate of incorporation, memorandum
of association, bylaws or other organizational documents of any of the Company’s Subsidiaries, (c) except for receipt of the Stockholder Approval, approval of the CFTC and the National Futures Association, expiration or early termination,
as the case may be, of all applicable waiting periods under the HSR Act, and filings under applicable securities laws required to comply with the Company’s registration obligations under the Registration Rights Agreement, or as set forth on
Schedule 3.2, do not violate, conflict with or result in any breach, default or contravention of (or with due notice or lapse of time or both would result in any breach, default or contravention of), or the creation of any Lien under,
any Contractual Obligation of the Company or its Subsidiaries or any material Requirement of Law applicable to the Company or its Subsidiaries and (d) except for approval of the CFTC and the National Futures 

  

 12 

 
Association, expiration or early termination, as the case may be, of all applicable waiting periods under the HSR Act, and filings under applicable
securities laws required to comply with the Company’s registration obligations under the Registration Rights Agreement, or as set forth on Schedule 3.2, do not violate any judgment, injunction, writ, award, decree or order of any
nature (collectively, “Orders”) of any Governmental Authority against, or binding upon, the Company or its Subsidiaries. 
  
 3.3 Governmental Authorization; Third Party Consents. Except (i) for the filing of the Certificate of Merger, the New Certificate of
Incorporation and the Exchange Certificate of Incorporation, each with the Secretary of State of the State of Delaware, after Stockholder Approval has been received, (ii) for such filings and notifications as may be required by the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”) and, if necessary, similar foreign competition or Antitrust Laws, (iii) for such consent, approval, order or authorization of, or registration,
declaration or filing with, the CFTC or the National Futures Association as are set forth on Schedule 3.3(iii), (iv) for the filing of the Proxy Statement with the Commission, (v) for filings under applicable securities laws
required to comply with the Company’s registration obligations under the Registration Rights Agreement and (vi) as set forth in Schedule 3.3(vi), no approval, consent, compliance, exemption, authorization or other action by, or
notice to, or filing with, any Governmental Authority, quasi-governmental entity with jurisdiction or supervision over the Company or its Subsidiaries or any other Person, and no lapse of a waiting period under a Requirement of Law, is necessary or
required in connection with the execution, delivery or performance (including, without limitation, effectiveness of the New Certificate of Incorporation and the sale, issuance and delivery of the Purchased Shares) by, or enforcement against, the
Company of this Agreement and the other Transaction Documents or the transactions contemplated hereby and thereby. 
  
 3.4 Binding Effect. This Agreement has been, and as of the Closing Date each of the other Transaction Documents will have been, duly executed and
delivered by the Company, and this Agreement constitutes, and as of the Closing Date each of the other Transaction Documents will constitute, the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with
their terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, fraudulent conveyance or transfer, moratorium or similar laws affecting the enforcement of creditors’ rights generally and by general
principles of equity relating to enforceability (regardless of whether considered in a proceeding at law or in equity). 
  
 3.5 Litigation. Except as set forth on Schedule 3.5 or as disclosed in the SEC Documents, as of the date of this Agreement, there are
no actions, suits, proceedings, claims, complaints, disputes, arbitrations or investigations (of which investigations the Company has written or oral notice) (collectively, “Claims”) pending or, to the Knowledge of the Company,
threatened, at law, in equity, in arbitration or before any Governmental Authority against the Company or its Subsidiaries nor, to the Knowledge of the Company, is the Company aware that there is any reasonable basis for any of the foregoing. As of
the Closing, except as set forth on Schedule 3.5, there shall 

  

 13 

 
be no Claims pending or, to the Knowledge of the Company, threatened, at law, in equity, in arbitration or before any Governmental Authority against the
Company or its Subsidiaries which would reasonably be expected to have a material adverse effect on the Condition of the Company. The foregoing includes, without limitation, Claims involving the prior employment of any of the employees of the
Company or its Subsidiaries, their use in connection with the Company’s business of any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers. No Order
has been issued by any court or other Governmental Authority against the Company purporting to enjoin or restrain the execution, delivery or performance of this Agreement or any of the other Transaction Documents. 
  
 3.6 Compliance with Laws. 
  
 (a) The Company and its Subsidiaries are in compliance in all material
respects with all Requirements of Law and all Orders of any Governmental Authority against the Company and such Subsidiaries. Except as set forth on Schedule 3.6(a), to the Company’s Knowledge, there is no existing or proposed
Requirement of Law which would reasonably be expected to prohibit or restrict the Company or its Subsidiaries from, or otherwise effect the Company or its Subsidiaries in, conducting their businesses in any jurisdiction in which they now conduct
such businesses which would reasonably be expected to have a material adverse effect on the Condition of the Company. 
  
 (b) (i) The Company and its Subsidiaries have all material licenses, permits and approvals of any Governmental Authority (collectively,
“Permits”) that are necessary for the conduct of the business of the Company and its Subsidiaries; (ii) such Permits are in full force and effect; and (iii) except as set forth on Schedule 3.6(b), no material
violations are or have been recorded in respect of any Permit. 
  
 3.7 Capitalization. 
  
 (a) As of the date of
this Agreement, the authorized capital stock of the Company consists of 816 shares of Common Stock and there are 816 shares of Common Stock issued and outstanding. On the Closing Date, after giving effect to the transactions contemplated by this
Agreement (including the issuance of the Purchased Shares), the authorized capital stock of the Company shall consist of (i) 200,000,000 shares of Common Stock, of which 73,440,000 shares shall be issued and outstanding, which includes
(A) 26,480,000 shares of Series A-1 Common Stock, of which 24,480,000 shares shall be issued and outstanding, (B) 26,480,000 shares of Series A-2 Common Stock, of which 24,480,000 shares shall be issued and outstanding and
(C) 26,480,000 shares of Series A-3 Common Stock, of which 24,480,000 shares shall be issued and outstanding and (ii) 8,160,000 shares of Preferred Stock, of which 8,160,000 shares shall be issued and outstanding. As of the Closing Date,
the Company shall reserve an aggregate of 8,160,000 shares of Unrestricted Common Stock for issuance upon conversion of the Purchased Shares. Except as set forth on Schedule 3.7(a) or as 

  

 14 

 
disclosed in the SEC Documents, there are no options, warrants, conversion privileges, subscription or purchase rights or other rights outstanding as of the
date of this Agreement to purchase or otherwise acquire (i) any authorized but unissued, unauthorized or treasury shares of the Company’s capital stock, (ii) any Stock Equivalents or (iii) any other securities of the Company and
there are no commitments, contracts, agreements, arrangements or understandings by the Company to issue any shares of the Company’s capital stock or any Stock Equivalents or other securities of the Company. On the Closing Date, the Purchased
Shares shall be duly authorized, and when issued and sold to the Purchasers against payment therefor, will be validly issued, fully paid and non-assessable, will be issued on the basis of a valid exemption from the registration and qualification
requirements of all applicable federal, state and foreign securities laws (assuming the truth and accuracy of the representations and warranties of the Purchasers contained in Article IV) and will be free and clear of all Liens, other than
(w) those imposed by the Securities Act, (x) those imposed by the New Certificate of Incorporation or the New Bylaws, (y) those imposed by the Investor Rights Agreement or the Registration Rights Agreement or (z) any Lien created
by a Purchaser. The shares of Unrestricted Common Stock issuable upon conversion of the Purchased Shares, when issued in compliance with the provisions of the New Certificate of Incorporation, will be validly issued, fully paid and non-assessable
and not subject to any preemptive rights or similar rights that have not been satisfied and will be free and clear of all other Liens, other than (w) those imposed by the Securities Act, (x) those imposed by the New Certificate of
Incorporation or the New Bylaws, (y) those imposed by the Investor Rights Agreement or Section 6 of the Registration Rights Agreement or (z) any Lien created by a Purchaser. All of the issued and outstanding shares of Common Stock are
duly authorized, validly issued, fully paid and non-assessable, and were issued on the basis of a valid exemption from the registration and qualification requirements of all applicable federal, state and foreign securities laws. 
  
 (b) Schedule 3.7(b) sets forth, as of the date hereof, a true
and complete list of (i) each of the Subsidiaries of the Company, (ii) the authorized capital stock of each such Subsidiary, (iii) the amount and percentage of the authorized shares of capital stock of each such Subsidiary owned by
the Company, (iv) except in the case of each of the Exchanges, the stockholders of each such Subsidiary and, opposite the name of each stockholder, the amount of all outstanding capital stock and Stock Equivalents owned by such stockholder and
(v) in the case of the Exchanges, the aggregate number of members and the aggregate amount of all outstanding capital stock, Stock Equivalents and membership interests by class owned by such members. All of such shares of capital stock are duly
authorized, validly issued, fully paid and non-assessable, and were issued in compliance with the registration and qualification requirements of all applicable federal, state and foreign securities laws and are owned free and clear of all Liens.
Except as set forth on Schedule 3.7(b), there are no options, warrants, conversion privileges, subscription or purchase rights or other rights presently outstanding to purchase or otherwise acquire any authorized but unissued,
unauthorized or treasury shares of capital stock or other securities of, or any proprietary interest in, any of the Subsidiaries, and there is no outstanding security of any kind convertible into or exchangeable for such shares or proprietary
interest. Except as set forth on 

  

 15 

 
Schedule 3.7(b), neither the Company nor any of its Subsidiaries, owns any interest, or has a right to acquire any interest, in any Person that
is not a Subsidiary. 
  
 (c) The Purchased Shares to be purchased
by the Purchasers hereunder represent, in the aggregate, on the Closing Date, 10% of the outstanding shares of Common Stock on a fully diluted basis assuming the conversion, exercise or exchange of any outstanding securities into shares of Common
Stock, including, without limitation, all of the Purchased Shares immediately following the Closing. 
  
 (d) There is no established trading market for the Common Stock (other than as a result of, prior to the Closing Date, being “stapled” to the
Trading Rights for which there is a trading market) and the Common Stock is not listed on any exchange or automated quotation system. 
  
 3.8 SEC Documents; Financial Statements. Since January 1, 2002, the Company has filed all reports, schedules, forms, statements and other
documents required to be filed by it with the Commission pursuant to the reporting requirements of the Exchange Act (all of the foregoing filed prior to the date hereof and all exhibits included therein and financial statements and schedules thereto
and documents incorporated by reference therein being hereinafter referred to as the “SEC Documents”). As of their respective dates (or if amended or superseded by a filing at least two Business Days prior to the date of this
Agreement, then on the date of such filing), the SEC Documents complied in all material respects with the requirements of the Exchange Act and the rules and regulations of the Commission promulgated thereunder applicable to the SEC Documents, and
none of the SEC Documents, at the time they were filed with the Commission (or if amended or superseded by a filing at least two Business Days prior to the date of this Agreement, then on the date of such filing), contained any untrue statement of a
material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. As of their respective dates (or if
amended or superseded by a filing at least two Business Days prior to the date of this Agreement, then on the date of such filing), the financial statements of the Company (the “Financial Statements”) included in the SEC Documents
complied as to form in all material respects with applicable accounting requirements and the published rules and regulations of the Commission with respect thereto. The Financial Statements have been prepared in accordance with GAAP, consistently
applied, during the periods involved (except in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) and fairly present in all material respects the financial position of the
Company as of the dates thereof and the results of its operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments). 
  
 3.9 Material Contracts. 
  
 (a) Schedule 3.9(a) sets forth a list of all contracts,
agreements, commitments, arrangements, leases (including with respect to personal property) and other instruments which have not been fully performed and for which the Company or 

  

 16 

 
any of its Subsidiaries has any continuing obligations or liabilities thereunder (to which the Company or any of its Subsidiaries is a party or by which the
Company, any of its Subsidiaries or any of their respective assets is bound) that involve or could involve aggregate payments of more than $1,000,000 per year that (A) have not previously been filed as an exhibit to the SEC Documents,
(B) are not set forth on Schedule 3.16(a)(iii), (C) are not liabilities and obligations for fees and expenses incurred in connection with this transaction and (D) do not relate to routine overhead and administrative costs
or expenses with respect to the facilities of the Company or its Subsidiaries that are incurred in the ordinary course of business, consistent with past practices (such contracts, agreements, commitments, arrangements, leases (including with respect
to personal property), together with any contract, agreement or understanding required to be set forth on Schedule 3.9(c) or filed as an exhibit to the SEC Documents, each, a “Material Contract” and collectively, the
“Material Contracts”). Copies of all Material Contracts have been previously delivered to or made available by the Company for inspection by the Purchasers, and such copies are true, complete and correct. 
  
 (b) There is no Material Contract that was required to be described in or
filed as an exhibit to any SEC Document that was not described in or filed as required by the Securities Act or the Exchange Act, as the case may be. The Material Contracts set forth on Schedule 3.9(a) are valid and binding and are in
full force and effect and enforceable in accordance with their respective terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws relating to or affecting the rights and remedies of creditors generally and to
general principles of equity (regardless of whether considered in a proceeding in equity or at law). The Company is not, in any material respect, in violation or breach of or default under any Material Contract nor, to the Company’s Knowledge,
is any other party to any such Material Contract. 
  
 (c) Except
as set forth on Schedule 3.9(c) or disclosed in the SEC Documents, neither the Company nor any of its Subsidiaries is a party to or bound by any contract, agreement or arrangement (including any lease of real property),
(i) restricting the ability of the Company or any of its Subsidiaries to compete in any material respect in or conduct any line of business or to engage in business in any geographic area or to hire any individual or group of individuals,
(ii) containing covenants of any other Person not to compete in any material respect with the Company or any of its Subsidiaries, (iii) containing any so-called “most favored nation” provisions or any similar provision requiring
the Company or any Subsidiary to offer a third party terms or concessions at least as favorable as offered to one or more other parties, (iv) providing for “earn-outs,” “performance guarantees” or contingent payments by the
Company or any of its Subsidiaries involving more than $1,000,000 per year, (v) relating to Indebtedness for borrowed money, letters of credit, the deferred purchase price of property, conditional sale arrangements, capital lease obligations,
obligations secured by a Lien, or interest rate or currency hedging activities (including guarantees or other contingent liabilities in respect of any of the foregoing but in any event excluding trade payables arising in the ordinary course of
business consistent with past practice, intercompany indebtedness and immaterial leases for telephones, copy machines, facsimile machines and other office equipment) or (vi) relating to any material joint 

  

 17 

 
venture, partnership, strategic alliance or similar arrangement (including, without limitation, any franchising agreement). 
  
 3.10 No Material Adverse Change; Ordinary Course of Business. Since
December 31, 2004, except as disclosed in the SEC Documents, (a) there has not been any material adverse change in the Condition of the Company, other than those adverse changes occurring as a result of (i) general economic, market or
industry conditions (including, without limitation, any change in trading prices of the Trading Rights), which do not have a disproportionate effect on the Company or its Subsidiaries as compared to other persons in the industry in which the Company
and its Subsidiaries conduct business, (ii) the initiation, continuation, escalation or cessation of armed hostilities involving the United States or its territories or (iii) the existing or proposed Requirements of Law identified on
Schedule 3.6(a), (b) except as set forth on Schedule 3.10(b), the Company and its Subsidiaries have not participated in any transaction material to the Condition of the Company or otherwise acted outside the ordinary
course of business, including, without limitation, declaring or paying any dividend or declaring or making any distribution to its stockholders except out of the earnings of the Company and its Subsidiaries, as the case may be, (c) except as
set forth on Schedule 3.10(c), the Company and its Subsidiaries have not increased the compensation of any of their officers or the rate of pay of any of their employees, except as part of regular compensation increases in the ordinary
course of business, (d) the Company and its Subsidiaries have not created or assumed any Lien on a material asset of the Company and its Subsidiaries, (e) the Company and its Subsidiaries have not entered into any Contractual Obligation,
other than in the ordinary course of business and (f) there has not occurred a material change in the accounting principles or practice of the Company or any of its Subsidiaries except as required by reason of a change in GAAP. 
  
 3.11 Taxes. Except as set forth on Schedule 3.11,
(a) the Company and its Subsidiaries have timely filed or caused to be filed all material returns for Taxes that they are required to file on and through the date hereof (including all applicable extensions), and all such Tax returns are
accurate and complete; (b) the Company and its Subsidiaries have paid in full, or made adequate provision on its Financial Statements (in accordance with GAAP) for, all material Taxes with respect to periods ending on or before the date of its
Financial Statements; (c) with respect to all Tax returns of the Company and its Subsidiaries, (i) there is no unpaid Tax deficiency proposed in writing against the Company or its Subsidiaries and (ii) no audit is in progress with
respect to any material return for Taxes, no extension of time is in force with respect to any date on which any material return for Taxes was or is to be filed and no waiver or agreement is in force for the extension of time for the assessment or
payment of any Tax; (d) the Company and its Subsidiaries have paid in full or made adequate provision on its books and records for all material Taxes with respect to periods ending after the date of its most recent Financial Statements through
the date hereof; and (e) there are no Liens for Taxes on the assets of the Company and its Subsidiaries, other than Liens for Taxes not yet due and payable. 
  

 18 

 3.12 Private Offering. No form of general solicitation or general advertising was used by the
Company or its representatives in connection with the offer, sale or issuance of the Purchased Shares. Assuming the truth and accuracy of the representations and warranties of the Purchasers contained in Article IV, no registration of the
Purchased Shares, pursuant to the provisions of the Securities Act or any state securities or “blue sky” laws, will be required by the offer, sale or issuance of the Purchased Shares. The Company agrees that neither it, nor anyone acting
on its behalf, shall offer to sell the Purchased Shares or any other securities of the Company so as to require the registration of the Purchased Shares pursuant to the provisions of the Securities Act or any state securities or “blue sky”
laws, unless such Purchased Shares or other securities are so registered. 
  
 3.13 Labor Relations. (a) Neither the Company nor any of its Subsidiaries is engaged in any unfair labor practice; (b) there is (i) no grievance or arbitration proceeding arising out of or under
collective bargaining agreements pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries, and (ii) no strike, labor dispute, slowdown or stoppage pending or, to the Knowledge of the Company,
threatened against the Company or any of its Subsidiaries; (c) neither the Company nor any of its Subsidiaries is a party to any collective bargaining agreement or contract; (d) there is no union representation question existing with
respect to the employees of the Company or any of its Subsidiaries; and (e) no union organizing activities are taking place. As of the date hereof, the Company has not discussed or taken any steps to terminate the employment of any such
officer, key employee or group of key employees. To the Knowledge of the Company, each of the officers and key employees of the Company and its Subsidiaries spends all, or substantially all, of his business time on the business of the Company or any
of its Subsidiaries. To the Knowledge of the Company, none of the employees of the Company or any of its Subsidiaries is resident in the United States in violation of any Requirement of Law. 
  
 3.14 Employee Benefit Plans. 
  
 (a) Schedule 3.14(a) hereto and the SEC Documents together list
each Plan that the Company or any of its Subsidiaries maintain or to which the Company or any of its Subsidiaries contribute (the “Company Plans”). The Company and its Subsidiaries have no liability under any Plans other than the
Company Plans. Except as set forth on Schedule 3.14(a), neither the Company nor its Subsidiaries nor any Commonly Controlled Entity maintains or contributes to, or has within the preceding six years maintained or contributed to, any Plan
subject to Title IV of ERISA or Section 412 of the Code or any “multiple employer plan” within the meaning of the Code or ERISA. Each Company Plan (and related trust, insurance contract or fund) has been established and
administered in all material respects in accordance with its terms, and complies in all material respects in form and in operation with the applicable requirements of ERISA and the Code and other applicable Requirements of Law. All contributions
(including all employer contributions and employee salary reduction contributions) which are due have been paid to each Company Plan. 
  

 19 

 (b) No Claim with respect to the administration or the investment of the assets of any Company Plan
(other than routine claims for benefits) is pending. 
  
 (c) The
Internal Revenue Service has issued a favorable determination letter with respect to each Company Plan that is intended to be qualified under Section 401(a) of the Code and to the Knowledge of the Company, no events have occurred that could
reasonably be expected to result in the revocation of such determination. 
  
 (d) Except as set forth in Schedule 3.14(d), no Company Plan is a Retiree Welfare Plan. 
  
 (e) The consummation of the transactions contemplated by this Agreement will not accelerate the time of the payment or vesting of, or increase the amount
of, compensation due to any employee or former employee whether or not such payment would constitute an “excess parachute payment” under section 280G of the Code. 
  
 (f) There are no unfunded obligations under any Company Plan which are not fully reflected on the Financial Statements in
accordance with GAAP (to the extent required). 
  
 (g) Neither
the Company nor any of its Subsidiaries has any liability, whether absolute or contingent, including any obligations under any Company Plan, with respect to any misclassification of any person as an independent contractor rather than as an employee.

  
 3.15 Liabilities. The Company and its Subsidiaries do
not have any direct or indirect obligation or liability (the “Liabilities”) other than (a) Liabilities fully and adequately reflected in or reserved against on the Financial Statements or otherwise disclosed in the SEC
Documents, (b) Liabilities incurred since December 31, 2004 in the ordinary course of business and (c) Liabilities not exceeding $500,000 in the aggregate or otherwise immaterial in the aggregate, in each case which are not required
to be disclosed in the Financial Statements. 
  
 3.16
Intellectual Property. 
  
 (a) (i) The Company and its
Subsidiaries are the owners of all, or have the license or right to use, sell and license, as applicable, all of, the Copyrights, Patents, Trade Secrets, Trademarks, Internet Assets, Software and other proprietary rights (collectively,
“Intellectual Property”) as such Intellectual Property is used in connection with their businesses as presently conducted or contemplated in the business plan of the Company and its Subsidiaries, free and clear of all Liens.

  
 (ii) Schedule 3.16(a)(ii) sets forth all of
the filings, registrations and applications for any Intellectual Property filed by, the Company, which have not previously been filed as an exhibit to the SEC Documents. Except as set forth on 

  

 20 

 
Schedule 3.16(a)(ii), none of the Intellectual Property listed on Schedule 3.16(a)(ii) is subject to any outstanding Order, and no action,
suit, proceeding, hearing, investigation, charge, complaint, claim or demand is pending in writing or, to the Knowledge of the Company, threatened, which challenges the validity, enforceability, use or ownership of the item. 
  
 (iii) Schedule 3.16(a)(iii) sets forth all material Intellectual
Property licenses, sublicenses, distributor agreements and other agreements under which the Company or its Subsidiaries are either a licensor, licensee or distributor, which have not previously been filed as an exhibit to the SEC Documents (except
such licenses, sublicenses and other agreements relating to off-the-shelf software, which is commercially available on a retail basis and used solely on the computers of the Company or its Subsidiaries. The Company and its Subsidiaries have
substantially performed all obligations imposed upon them thereunder, and are not, nor to the Knowledge of the Company is any other party thereto, in breach of or default thereunder in any respect, nor is there any event which with notice or lapse
of time or both would constitute a default thereunder. To the Knowledge of the Company, all such Intellectual Property licenses are valid, enforceable and in full force and effect, and will continue to be so on identical terms immediately following
the Closing, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, fraudulent conveyance or transfer, moratorium or similar laws affecting the enforcement of creditors’ rights generally and by general
principles of equity relating to enforceability (regardless of whether considered in a proceeding at law or in equity). 
  
 (iv) To the Knowledge of the Company, other than as set forth on Schedule 3.16(a)(iv) or as previously disclosed in the SEC Documents,
none of the Intellectual Property, products or services currently sold, provided or licensed by the Company or its Subsidiaries to any Person or used by or licensed to the Company or its Subsidiaries by any Person infringes upon or otherwise
violates any Intellectual Property rights of others. 
  
 (v)
Except as set forth on Schedule 3.16(a)(v) or as previously disclosed in the SEC Documents, no litigation is pending and no Claim has been made against the Company or its Subsidiaries or, to the Knowledge of the Company, is
threatened, contesting the right of the Company or its Subsidiaries to sell or license to any Person or use the Intellectual Property presently sold or licensed to such Person or used by the Company or its Subsidiaries. 
  
 (b) Except as set forth on Schedule 3.16(b) or as previously
disclosed in the SEC Documents, to the Knowledge of the Company, no Person is infringing upon or otherwise violating the Intellectual Property rights of the Company and its Subsidiaries. 
  
 (c) No former employer of any employee of the Company or its Subsidiaries, has made a Claim against the Company, or its
Subsidiaries or, to the Knowledge of the Company, against any of the Company’s or Subsidiaries’ Affiliates or 

  

 21 

 
other Person, that such employee is utilizing Intellectual Property of such former employer. 
  
 (d) To the Knowledge of the Company, none of the Trade Secrets of the Company or its Subsidiaries, wherever located, the
value of which is contingent upon maintenance of confidentiality thereof, has been disclosed to any Person who is not required to maintain such confidentiality, except as required pursuant to the filing of a patent application by the Company or its
Subsidiaries. 
  
 (e) Schedule 3.16(e)(i) sets forth
the Intellectual Property owned by any director, officer, employee or consultant of the Company or its Subsidiaries (or Persons the Company or any of its Subsidiaries presently intend to hire) that is necessary for the business of the Company and
its Subsidiaries. Except as set forth on Schedule 3.16(e)(ii), to the Company’s Knowledge, at no time during the conception or reduction to practice of any of the Company’s or its Subsidiaries’ Intellectual Property was
any developer, inventor or other contributor to such Intellectual Property operating under any grants from any Governmental Authority or subject to any employment agreement, invention assignment, nondisclosure agreement or other Contractual
Obligation with any Person that would not reasonably be expected to have a material adverse effect on the Company’s or such Subsidiaries’ rights to their Intellectual Property. 
  
 (f) All present employees of the Company and its Subsidiaries named as an inventor in any of the pending Patent applications
listed on Schedule 3.16(a)(ii) have executed and delivered proprietary invention agreements with the Company or such Subsidiaries, as the case may be, and are obligated under the terms thereof to assign all inventions subject to such
Patent applications to the Company or its Subsidiaries. 
  
 3.17
Privacy of Customer Information. The Company and its Subsidiaries each have a privacy policy with respect to information, including, without limitation, non-public financial information it collects from customers or other parties (the
“Customer Information”) (each a “Privacy Policy”) set forth on Schedule 3.17, true and complete copies of which have been provided to the Purchasers. To the Knowledge of the Company, neither the Company
nor any of its Subsidiaries has collected, received or used any Customer Information in an unlawful manner or in violation of its applicable Privacy Policy. The Company has commercially reasonable (taking into account the nature of the information
being collected) security measures and safeguards in place to protect the Customer Information from illegal or unauthorized access, download or use by its personnel or third parties, and from access, download or use by its personnel or third parties
in a manner violative of Law, or the applicable Privacy Policy or the privacy rights of any individuals, and, to the Knowledge of the Company, no Person has gained unauthorized access to or made any unauthorized use of any Customer Information. The
Company has adopted written information security programs designed to protect all Customer Information, copies of which have been provided to Purchaser. 
  

 22 

 3.18 Potential Conflicts of Interest. Except for transactions related to the clearing of
securities in the ordinary course of business and except for trading on the floor of each of the Exchanges in the ordinary course of business, as disclosed in the SEC Documents, or as set forth on Schedule 3.18, no officer or director of
the Company or any of its Subsidiaries, no spouse of any such officer or director, and, to the Knowledge of the Company, no relative of such spouse or of any such officer or director and no Affiliate of any of the foregoing (a) owns, directly
or indirectly, any interest in (excepting less than one percent (1%) stock holdings for investment purposes in securities of publicly held and traded companies), or is an officer, director, employee or consultant of, any Person which is, or is
engaged in business as, a competitor, lessor, lessee, supplier, distributor, sales agent or customer of, or lender to or borrower from, the Company or any of its Subsidiaries; or (b) owns, directly or indirectly, in whole or in part, any
tangible or intangible property material to the conduct of the businesses of the Company or its Subsidiaries. No stockholder (a) is a lender to or borrower from the Company or any of its Subsidiaries, or (b) owns, directly or indirectly,
in whole or in part, any tangible or intangible property material to the conduct of the businesses of the Company or its Subsidiaries. 
  
 3.19 Outstanding Borrowing. Schedule 3.19 sets forth the amount of all Indebtedness of the Company and its Subsidiaries as of
September 30, 2005, the Liens that relate to such Indebtedness and that encumber the assets and the name of each lender thereof. No such Indebtedness is entitled to any voting rights in any matters voted upon by the holders of Common Stock. The
Company and its Subsidiaries have not incurred any Indebtedness since September 30, 2005 except for such Indebtedness incurred in the ordinary course of business and except for such Indebtedness that would not have a material adverse effect on
the Condition of the Company. 
  
 3.20 Environmental
Matters. The Company and its Subsidiaries are in compliance with all applicable Environmental Laws, except where the failure to be in compliance would not have a material adverse effect on the Condition of the Company. There is no civil,
criminal or administrative judgment, action, suit, demand, claim, hearing, notice of violation, investigation, proceeding, notice or demand letter pending or, to the Knowledge of the Company, threatened against the Company or its Subsidiaries
pursuant to Environmental Laws which would reasonably be expected to have a material adverse effect on the Condition of the Company. To the Knowledge of the Company, there are no past or present events, conditions, circumstances, activities,
practices, incidents, agreements, actions or plans which would reasonably be expected to prevent compliance with, or which have given rise to or will give rise to liability which would have a material adverse effect on the Condition of the Company,
under Environmental Laws. 
  
 3.21 Insurance. The Company
and its Subsidiaries maintain those insurance policies or binders of insurance identified on Schedule 3.21. Such policies and binders are valid and enforceable in accordance with their terms and are in full force and effect. None of such
policies will be affected by, or terminate or lapse by reason of, any transaction contemplated by this Agreement or any of the other Transaction Documents. 
  

 23 

 3.22 Controls. As required by Rule 13a-15 of the Exchange Act, the Company has established
and maintains (i) internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act), which is designed to provide reasonable assurance regarding the reliability of the Company’s financial reporting and its
preparation of financial statements for external purposes in accordance with GAAP and (ii) disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act), which are designed to ensure that all material information
required to be disclosed by the Company in the SEC Documents is accumulated and communicated to the Company’s management, as appropriate to allow timely decisions regarding required disclosure. The Company has disclosed, based on its most
recent evaluation of internal control over financial reporting, to the Company’s external auditors, the Audit Committee of the Board of Directors and to the Purchasers (i) all significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are reasonably likely to adversely affect in any material respect the Company’s ability to record, process, summarize and report financial information and (ii) any fraud,
whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting. Except as disclosed in the Company’s SEC Documents filed on or prior to the date
hereof, there have been no changes in the Company’s internal control over financial reporting. To the Knowledge of the Company, as of the date of this Agreement, the Company expects that its external auditors and its chief executive officer and
chief financial officer will be able to give, without qualification, the certifications and attestations required pursuant to the rules and regulations adopted pursuant to Section 404 of SOX, in the Company’s Form 10-K for the fiscal
year ending December 31, 2005. 
  
 3.23 CFTC Regulatory
Matters. 
  
 (a) Except as set forth on
Schedule 3.23, the Company and its Subsidiaries have complied in all material respects with and are in material compliance with all Commodities Laws, except for any previous non-compliance prior to January 1, 2002 that is not
reasonably expected to have a material continuing effect on the business and operations of the Company and its Subsidiaries. 
  
 (b) Except as set forth on Schedule 3.23, no material change is required in the Company’s or any of its Subsidiaries’ processes,
properties or procedures to comply with any Commodities Laws in effect on the date hereof or enacted as of the date hereof and scheduled to be effective after the date hereof, and neither the Company nor any of its Subsidiaries has received any
written notice or written communication of any material noncompliance with any Commodities Laws. 
  
 (c) The Company has made available to the Purchasers copies of all material correspondence with the CFTC over the past three years, including without
limitation all reports or correspondence relating to or arising out of any inspection, audit, investigation or similar proceeding performed by or on behalf of the CFTC during that period. 
  

 24 

 3.24 Stockholder Approval. The affirmative vote of (i) the holders of a majority of the
outstanding shares of Common Stock on the record date and (ii) the holders of a majority of the outstanding memberships of the Exchange on the record date, are the only votes of the Company’s stockholders or the members of the Exchange
necessary to approve the Fundamental Actions. For the purposes of this Agreement, “Fundamental Actions” means the approval and adoption (x) by the Company’s stockholders, of the Agreement and Plan of Merger, which shall
constitute approval of the New Certificate of Incorporation and the New Bylaws, and (y) by the Exchange’s members, of the Exchange Certificate of Incorporation and the Exchange Bylaws. 
  
 3.25 Proxy Statement. The proxy statement to be distributed to the
Company’s stockholders in connection with the solicitation of votes in favor of the Stockholder Approval (as amended or supplemented from time to time, the “Proxy Statement”), shall not, at the date the Proxy Statement is first
mailed to stockholders of the Company and at the time of the meeting of the stockholders, as the case may be, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading; provided that no representation is made by the Company with respect to the information furnished by the Purchasers concerning the Purchasers or
their Affiliates, including William E. Ford, for inclusion in the Proxy Statement pursuant to Section 8.2(a). The Proxy Statement, and any amendments or supplements thereto, when filed by the Company with the Commission, or when
distributed or otherwise disseminated to the Company’s stockholders, as applicable, shall comply as to form in all material respects with the requirements of the Exchange Act the rules and regulations thereunder and other applicable
Requirements of Law. 
  
 3.26 Broker’s, Finder’s or
Similar Fees. Except as set forth on Schedule 3.26, there are no brokerage commissions, finder’s fees or similar fees or commissions payable by the Company or any of its Subsidiaries in connection with the transactions
contemplated hereby based on any agreement, arrangement or understanding with the Company or any of its Subsidiaries or any action taken by any such Person. 
  
 ARTICLE IV  
  
 REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS 
  
 Each of the Purchasers represents and warrants, severally and not jointly, to the Company as follows: 
  
 4.1 Existence and Power. Such Purchaser (a) is a limited
partnership or limited liability company, as the case may be, duly organized and validly existing and in good standing under the laws of the jurisdiction of its formation and (b) has all requisite partnership or limited liability company, as
the case may be, power and authority to execute, deliver and perform its obligations under this Agreement and each of the other Transaction Documents to which it is a party. 
  

 25 

 4.2 Authorization; No Contravention. The execution, delivery and performance by such Purchaser of
this Agreement and each of the other Transaction Documents to which it is a party and the transactions contemplated hereby and thereby, (a) have been duly authorized by all necessary partnership or limited liability company, as the case may be,
action of such Purchaser, (b) do not contravene the terms of such Purchaser’s organizational documents, or any amendment thereof, (c) except for expiration or early termination, as case may be, of all applicable waiting periods under
the HSR Act, do not violate, conflict with or result in any breach or contravention of (or with due notice of lapse of time or both would result in any breach, default or contravention of), or the creation of any Lien under, any Contractual
Obligation of such Purchaser or any Requirement of Law applicable to such Purchaser (except for the Lien created on the Purchased Shares purchased by GapStar to secure certain of its obligations), and (d) except for expiration or early
termination, as the case may be, of all applicable waiting periods under the HSR Act, do not violate any Orders of any Governmental Authority against, or binding upon, such Purchaser. 
  
 4.3 Governmental Authorization; Third Party Consents. Except for such filings and notifications as may be
required by the HSR Act and, if necessary, similar foreign competition or Antitrust Laws, no approval, consent, compliance, exemption, authorization or other action by, or notice to, or filing with, any Governmental Authority or any other Person,
and no lapse of a waiting period under any Requirement of Law, is necessary or required in connection with the execution, delivery or performance (including, without limitation, the purchase of the Purchased Shares) by, or enforcement against, such
Purchaser of this Agreement and the other Transaction Documents or the transactions contemplated hereby and thereby. 
  
 4.4 Binding Effect. This Agreement has been, and as of the Closing Date each of the other Transaction Documents will have been, duly executed and
delivered by such Purchaser, and this Agreement constitutes, and as of the Closing Date each of the other Transaction Documents will constitute, the legal, valid and binding obligations of such Purchaser, enforceable against it in accordance with
their terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, fraudulent conveyance or transfer, moratorium or similar laws affecting the enforcement of creditors’ rights generally and by general
principles of equity relating to enforceability (regardless of whether considered in a proceeding at law or in equity). 
  
 4.5 Purchase for Own Account. The Purchased Shares to be acquired by such Purchaser pursuant to this Agreement are being or will be acquired for
its own account and with no intention of distributing or reselling such Purchased Shares or any part thereof in any transaction that would be in violation of the securities laws of the United States, any state of the United States or any foreign
jurisdiction, without prejudice, however, to the rights of such Purchaser at all times to sell or otherwise dispose of all or any part of such Purchased Shares under an effective registration statement under the Securities Act, or under an exemption
from such registration available under the Securities Act. If such Purchaser should in the future decide to dispose of any of such Purchased Shares, such Purchaser understands and agrees that it 

  

 26 

 
may do so only in compliance with the Securities Act and applicable state and foreign securities laws, as then in effect. Such Purchaser agrees to the
imprinting, so long as required by law, of a legend on certificates representing all of its Purchased Shares and shares of Unrestricted Common Stock issuable upon conversion of its Purchased Shares, as required by Section 151(f) of the Delaware
General Corporation Law, as necessary to reflect restrictions arising under the New Certificate of Incorporation, the Transaction Documents and to the following effect: 
  
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“ACT”), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY FOREIGN JURISDICTION. THE SECURITIES MAY NOT BE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE STATE AND
FOREIGN SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND SUCH LAWS. 
  
 4.6 Restricted Securities. Such Purchaser understands that the Purchased Shares will not be registered at the time of their issuance under the
Securities Act for the reason that the sale provided for in this Agreement is exempt pursuant to Section 4(2) of the Securities Act and that the reliance of the Company on such exemption is predicated in part on such Purchaser’s
representations set forth herein. 
  
 4.7 Broker’s,
Finder’s or Similar Fees. There are no brokerage commissions, finder’s fees or similar fees or commissions payable by such Purchaser in connection with the transactions contemplated hereby based on any agreement, arrangement or
understanding with such Purchaser or any action taken by such Purchaser. 
  
 4.8 Accredited Investor. Such Purchaser is an “Accredited Investor” within the meaning of Rule 501 of Regulation D under the Securities Act, as presently in effect. 
  
 ARTICLE V 
  
 CONDITIONS TO THE OBLIGATION OF THE PURCHASERS TO CLOSE 
  
 The obligation of the Purchasers to purchase the Purchased Shares, to pay the purchase price therefor at the Closing and to
perform their other obligations hereunder shall be subject to the satisfaction as determined by, or waiver by, GAP LP, on behalf of the Purchasers of the following conditions on or before the Closing Date. 
  
 5.1 Representations and Warranties. The representations and warranties
of the Company contained in Article III hereof shall be true and correct in all material respects (except for any such representations and warranties which are qualified by their terms by a reference to materiality or material adverse effect,
which representation as so qualified shall be true and correct in all respects) at and on the 

  

 27 

 
Closing Date as if made at and on such date; provided, however, that the representation and warranty made in Section 3.7(c) shall be true
and correct in all respects at the time made and as of the Closing Date as if made at and on such date. 
  
 5.2 Compliance with this Agreement. The Company shall have performed and complied in all material respects with all of its agreements set forth
herein that are required to be performed by the Company on or before the Closing Date. 
  
 5.3 Officer’s Certificate. The Purchasers shall have received a certificate from the Company, in form and substance reasonably satisfactory to the Purchasers, dated the Closing Date, and signed by the
Chief Executive Officer and the Chief Financial Officer (or acting Chief Financial Officer) of the Company, certifying as to the matters set forth in Section 5.1 and 5.2. 
  
 5.4 Secretary’s Certificate. The Purchasers shall have received a certificate from the Company, in form and
substance reasonably satisfactory to the Purchasers, dated the Closing Date and signed by the Secretary or an Assistant Secretary of the Company, certifying (a) that the Company is in good standing with the Secretary of State of the State of
Delaware, (b) that the attached copies of the New Certificate of Incorporation, the New Bylaws, resolutions of the Board of Directors approving this Agreement and the other Transaction Documents and the transactions contemplated hereby and
thereby, and resolutions of the stockholders of the Company approving the Fundamental Actions, are all true, complete and correct and remain unamended and in full force and effect, (c) that the attached copies of the resolutions of the Board of
Directors designating William E. Ford to serve as a member of the Board of Directors are true, complete and correct and remain unamended and in full force and effect and (d) as to the incumbency and specimen signature of each officer of
the Company executing this Agreement, the other Transaction Documents and any other document delivered in connection herewith on behalf of the Company. 
  
 5.5 Filing of Certificate of Merger. The Agreement and Plan of Merger shall have been approved by the Board of Directors, and following receipt of
Stockholder Approval, the Certificate of Merger containing the New Certificate of Incorporation shall have been duly filed by the Company with the Secretary of State of the State of Delaware in accordance with the General Corporation Law of the
State of Delaware, and the Purchasers shall have received evidence of such filing in form and substance reasonably satisfactory to GAP LP, on behalf of the Purchasers. The New Certificate of Incorporation and the Exchange Certificate of
Incorporation shall each be effective. 
  
 5.6 Purchased
Shares. The Company shall have delivered to each of the Purchasers certificates in definitive form representing the number of Purchased Shares set forth on the notice provided pursuant to Section 2.1, registered in the name of such
Purchaser. 
  
 5.7 Investor Rights Agreement. The Company
shall have duly executed and delivered to the Purchasers the Investor Rights Agreement. 
  

 28 

 5.8 Registration Rights Agreement. The Company shall have duly executed and delivered to the
Purchasers the Registration Rights Agreement. 
  
 5.9
Stockholder Approval. The Company shall have obtained the Stockholder Approval and the Purchasers shall have received satisfactory evidence thereof. 
  
 5.10 Opinion of Counsel. The Company shall have delivered to the Purchasers an opinion of Skadden, Arps, Slate, Meagher & Flom LLP, dated
the Closing Date in the form attached hereto as Exhibit G. 
  
 5.11 No Material Adverse Change. Since the date hereof, there shall have been no material adverse change in the Condition of the Company other than those adverse changes occurring as a result of (i) general economic, market or
industry conditions (including, without limitation, any change in trading prices of the Trading Rights), which do not have a disproportionate effect on the Company or its Subsidiaries as compared to other persons in the industry in which the Company
and its Subsidiaries conduct business, (ii) the initiation, continuation, escalation or cessation of armed hostilities involving the United States or its territories or (iii) the proposed Requirements of Law identified on
Schedule 3.6(a) hereto. 
  
 5.12 Consents and
Approvals. All consents, approvals, exemptions, authorizations, or other actions by, or notice to, or filings identified on Schedule 5.12, shall have been obtained and be in full force and effect, and the Purchasers shall have been
furnished with appropriate evidence thereof and all applicable waiting periods shall have expired without any action being taken or threatened which would have a material adverse effect on the Condition of the Company. 
  
 5.13 HSR Act. All applicable waiting periods under the HSR Act shall
have expired or early termination of such waiting periods will have been granted. 
  
 5.14 No Material Judgment or Order. There shall not be on the Closing Date any Order of a court of competent jurisdiction or any ruling of any Governmental Authority or any condition imposed under any
Requirement of Law which would (a) prohibit or restrict (i) the purchase of the Purchased Shares or (ii) the consummation of the transactions contemplated by this Agreement, (b) subject the Purchasers to any material penalty or
onerous condition under or pursuant to any Requirement of Law if the Purchased Shares were to be purchased hereunder or (c) restrict the operation of the business of the Company as conducted on the date hereof in a manner that would have a
material adverse effect on the Condition of the Company. 
  
 5.15
Good Standing Certificates. The Company shall have delivered to the Purchasers good standing certificates for the Company and each of its Subsidiaries. 
  

5.16 New Bylaws; Board of Directors. The New Bylaws shall have been duly approved by the Board of Directors, and following receipt of
Stockholder Approval, be effective; and in accordance with the New Bylaws, the size of the Board of 

  

 29 

 
Directors shall have been reduced to fifteen (15) members. William E. Ford shall have been appointed a member of the Board of Directors. 
  
 5.17 Separation of Rights. 
  
 (a) The Common Stock and membership rights that represent trading privileges
on the Exchange (such membership rights, the “Trading Rights”) of the stockholders of record of the Company immediately prior to Closing shall have been “de-stapled” as contemplated by the Exchange Certificate of
Incorporation and the New Certificate of Incorporation. 
  
 (b)
The Trading Rights shall otherwise remain unchanged, subject to the provisions of the New Certificate of Incorporation and the Exchange Certificate of Incorporation and the Exchange Bylaws. 
  
 5.18 Closing Payment. The Company shall have paid to the Purchasers
the Special Payment, if any. 
  
 ARTICLE VI 
  
 CONDITIONS TO THE OBLIGATION OF THE COMPANY TO CLOSE 
  
 The obligation of the Company to issue and sell the Purchased Shares at the
Closing and to perform its other obligations hereunder shall be subject to the satisfaction as determined by, or waiver by, the Company of the following conditions on or before the Closing Date. 
  
 6.1 Representations and Warranties. The representations and warranties
of each Purchaser contained in Article IV hereof shall be true and correct in all material respects (except for any such representations and warranties which are qualified by their terms by a reference to materiality or material adverse effect,
which representation as so qualified shall be true and correct in all respects) at and on the Closing Date as if made at and on such date. 
  
 6.2 Compliance with this Agreement. Each Purchaser shall have performed and complied in all material respects with all of its agreements set forth
herein that are required to be performed by such Purchaser on or before the Closing Date. 
  
 6.3 Officer’s Certificate. The Company shall have received a certificate from each Purchaser, in form and substance reasonably satisfactory to the Company, dated the Closing Date, and signed by an
appropriate officer of such Purchaser, certifying as to the matters set forth in Section 6.1 and 6.2. 
  
 6.4 Certificate. The Company shall have received a certificate from each Purchaser, in form and substance reasonably satisfactory to the Company,
dated the Closing Date and signed by an authorized representative of such Purchaser, certifying (a) that such Purchaser is in good standing in the jurisdiction of formation and (b) as to 

  

 30 

 
the incumbency and specimen signature of each officer of such Purchaser executing this Agreement, the other Transaction Documents and any other document
delivered in connection herewith on behalf of such Purchaser. 
  
 6.5 Payment of the Purchase Price. Each Purchaser shall have paid the Company the aggregate purchase price for the Purchased Shares to be purchased by such Purchaser. 
  
 6.6 Investor Rights Agreement. Each Purchaser shall have duly executed and delivered to the Company the Investor
Rights Agreement. 
  
 6.7 Registration Rights Agreement.
Each Purchaser shall have duly executed and delivered to the Company the Registration Rights Agreement. 
  
 6.8 HSR Act. All applicable waiting periods under the HSR Act shall have expired or early termination of such waiting periods will have been
granted. 
  
 6.9 Stockholder Approval. The Company shall
have obtained the Stockholder Approval. 
  
 6.10 Consents and
Approvals. All consents, exemptions, authorizations, or other actions by, or notice to, or filings identified on Schedule 6.10 shall have been obtained and be in full force and effect, and all applicable waiting periods shall have
expired without any action being taken or threatened which would have a material adverse effect on the Condition of the Company. 
  
 6.11 No Material Judgment or Order. There shall not be on the Closing Date any Order of a court of competent jurisdiction or any ruling of any
Governmental Authority or any condition imposed under any Requirement of Law which would, (a) prohibit or restrict (i) the sale of the Purchased Shares or (ii) the consummation of the transactions contemplated by this Agreement,
(b) subject the Company to any material penalty or onerous condition under or pursuant to any Requirement of Law if the Purchased Shares were to be sold hereunder or (c) restrict the operation of the business of the Company as conducted on
the date hereof in a manner that would have a material adverse effect on the Condition of the Company. 
  
 ARTICLE VII 
  
 INDEMNIFICATION 
  
 7.1 Indemnification.
Except as otherwise provided in this Article VII, from and after the Closing the Company (the “Indemnifying Party”) agrees to indemnify, defend and hold harmless each of the Purchasers and their respective officers, directors,
agents, employees, Subsidiaries, partners, members and controlling persons (each, an “Indemnified Party”) to the fullest extent permitted by law from and against any and all losses, Claims, or written threats thereof (including,
without limitation, any Claim by a third party), damages, expenses (including reasonable fees, disbursements and other 

  

 31 

 
charges of counsel incurred by the Indemnified Party in any action between the Indemnifying Party and the Indemnified Party or between the Indemnified Party
and any third party or otherwise) or other liabilities (collectively, “Losses”) resulting from or arising out of any breach of any representation or warranty, covenant or agreement by the Company in this Agreement. The amount of any
payment to any Indemnified Party herewith in respect of any Loss shall be of sufficient amount to make such Indemnified Party whole for any diminution in value of the Purchased Shares. In connection with the obligation of the Indemnifying Party to
indemnify for expenses as set forth above, the Indemnifying Party shall, upon presentation of appropriate invoices containing reasonable detail, reimburse each Indemnified Party for all such expenses (including reasonable fees, disbursements and
other charges of counsel incurred by the Indemnified Party in any action between the Indemnifying Party and the Indemnified Party or between the Indemnified Party and any third party) as they are incurred by such Indemnified Party; provided,
however, that if an Indemnified Party is reimbursed under this Article VII for any expenses, such reimbursement of expenses shall be refunded to the extent it is finally judicially determined that the Losses in question resulted
primarily from the willful misconduct or gross negligence of such Indemnified Party. 
  
 7.2 Notification. Each Indemnified Party under this Article VII shall, promptly after the receipt of notice of the commencement of any Claim against such Indemnified Party in respect of which indemnity may
be sought from the Indemnifying Party under this Article VII, notify the Indemnifying Party in writing of the commencement thereof. The omission of any Indemnified Party to so notify the Indemnifying Party of any such action shall not relieve
the Indemnifying Party from any liability which it may have to such Indemnified Party (a) other than pursuant to this Article VII or (b) under this Article VII unless, and only to the extent that, such omission results in the
Indemnifying Party’s forfeiture of substantive rights or defenses. In case any such Claim shall be brought against any Indemnified Party, and it shall notify the Indemnifying Party of the commencement thereof, the Indemnifying Party shall be
entitled to assume the defense thereof at its own expense, with counsel satisfactory to such Indemnified Party in its reasonable judgment; provided, however, that any Indemnified Party may, at its own expense, retain separate counsel
to participate (subject to the Indemnifying Party’s right to control the defense in accordance with this Section 7.2) in such defense at its own expense. Notwithstanding the foregoing, in any Claim in which both the Indemnifying Party, on
the one hand, and an Indemnified Party, on the other hand, are, or are reasonably likely to become, a party, such Indemnified Party shall have the right to employ separate counsel and to control its own defense (in accordance with this
Section 7.2) of such Claim if, in the reasonable opinion of counsel to such Indemnified Party, either (x) one or more defenses are available to the Indemnified Party that are not available to the Indemnifying Party and which the
Indemnified Party is not reasonably able to assert or (y) a conflict or potential conflict exists between the Indemnifying Party, on the one hand, and such Indemnified Party, on the other hand, that would make such separate representation
advisable; provided, however, that the Indemnifying Party shall not be liable for the fees and expenses of more than one counsel to all Indemnified Parties. The Indemnifying Party agrees that it will not, without the prior written
consent of the Purchasers, settle, compromise or consent to 

  

 32 

 
the entry of any judgment in any pending or threatened Claim relating to the matters contemplated hereby (if any Indemnified Party is a party thereto) unless
such settlement, compromise or consent includes an unconditional release of each Indemnified Party from all liability arising or that may arise out of such Claim; provided that, the Indemnifying Party shall use commercially reasonable
efforts to include any Indemnified Party in such settlement, compromise or consent if such Indemnified Party has been actually threatened to be made a party thereto. The Indemnifying Party shall not be liable for any settlement of any Claim effected
against an Indemnified Party without its written consent, which consent shall not be unreasonably withheld. The rights accorded to an Indemnified Party under this Article VII shall be the exclusive remedy that any Indemnified Party may have at
common law, by separate agreement or otherwise; provided, however, that notwithstanding the foregoing or anything to the contrary contained in this Agreement, nothing in this Article VII shall restrict or limit any rights that any
Indemnified Party may have to seek equitable relief, including any right to any remedy set forth in Section 10.7. 
  
 7.3 Contribution. If the indemnification provided for in this Article VII from the Indemnifying Party is due in accordance with the terms
hereof, but is unavailable to an Indemnified Party hereunder in respect of any Losses referred to herein as a result of a final, non-appealable determination by a Governmental Authority that such indemnification is not enforceable, then the
Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a result of such Losses in such proportion as is appropriate to reflect the relative fault of the
Indemnifying Party and Indemnified Party in connection with the actions which resulted in such Losses, as well as any other relevant equitable considerations. The relative faults of such Indemnifying Party and Indemnified Party shall be determined
by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, has been made by, or relates to information supplied
by, such Indemnifying Party or Indemnified Party, and the parties relative intent, knowledge, access to information and opportunity to correct or prevent such action. The amount paid or payable by a party as a result of the Losses referred to above
shall be deemed to include, subject to the limitations set forth in Sections 7.1 and 7.2, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding but shall be subject to
the limits set forth in Section 7.4. 
  
 7.4 Limits on
Indemnification. The amount of any payment by the Indemnifying Party under this Article VII shall be subject to the following limitations: 
  
 (a) the Indemnifying Party shall not be obligated to make any payments pursuant to this Article VII until the aggregate amount of Losses for which
the Indemnifying Party would (but for this Section 7.4(a)) be liable thereunder exceeds $2,000,000.00 (the “Basket”), and then only for amounts in excess of the Basket; provided, however, that Losses based upon,
arising out of or otherwise relating to any breach of the representations and warranties of the Company in the second sentence of Section 3.1, Section 3.2(a) or (b), Section 3.3 (but only to the extent the breach arises from the
failure to obtain the approval, consent, compliance, exemption, authorization or 

  

 33 

 
other action by, or notices to, or filing with any Governmental Authority or quasi-governmental authority), Section 3.4, Section 3.7 and
Section 3.26 (the “Basket Exclusions”) shall not be subject to the Basket; and 
  
 (b) the total amount for which the Indemnifying Party shall be liable to indemnify and hold harmless the Indemnified Parties pursuant to this
Article VII shall not exceed $67,500,000 (other than Losses based upon, arising out of or otherwise relating to the Basket Exclusions for which the total amount for which the Indemnifying Party shall be liable, when combined with its liability
otherwise pursuant to this Section 7.4(b), shall not exceed $135,000,000.00). 
  
 (c) Unless otherwise required by applicable Law, the parties hereto agree to treat any payment made pursuant to this Article VII as an adjustment to the consideration paid by the Purchasers pursuant to this
Agreement for all tax purposes. 
  
 (d) In no event shall an
Indemnifying Party be liable for speculative, unforeseeable, punitive, exemplary or consequential damages or lost profits; provided, however, that nothing in this Section 7.4(d) shall affect any Purchaser’s right to be
indemnified by an Indemnifying Party pursuant to this Article VII for the diminution in value of such Purchaser’s Purchased Shares. Notwithstanding any provision contained herein to the contrary, no Indemnified Party shall be entitled to
indemnification or contribution hereunder with respect to a breach by the Indemnifying Party of any representations or warranties of which such Indemnified Party had actual knowledge of such breach at or prior to the Closing. For the purposes of
this Section 7.4(d), knowledge of an Indemnified Party shall mean the actual knowledge of William E. Ford, Peter L. Bloom, Rene M. Kern, David A. Rosenstein or Stephen J. Byrne. 
  
 ARTICLE VIII  
  
 AFFIRMATIVE COVENANTS 
  
 The Company hereby covenants and agrees with the Purchasers as follows:

  
 8.1 Conduct of Business of the Company. Except as
contemplated by this Agreement (including, without limitation, the NYMEX Merger or the proviso in Section 8.3) or with the prior written consent of the Purchasers, during the period from the date of this Agreement to the Closing Date, the
Company will conduct its and its Subsidiaries’ operations only in the ordinary course of business consistent with past practice and, to the extent consistent therewith, with no less diligence and effort then would be applied in the absence of
this Agreement, will use its commercially reasonable efforts to preserve intact the business organization of the Company and its Subsidiaries and to preserve the goodwill of customers, suppliers and all other Persons having business relationships
with the Company and its Subsidiaries. Without limiting the generality of the foregoing, and except as otherwise contemplated by this Agreement, prior to the Closing Date, the Company will not and the Company will cause its Subsidiaries not to,
without the prior written consent of the Purchasers, which consent 

  

 34 

 
will not be unreasonably withheld or delayed: (a) engage in any transaction (including, without limitation, capital expenditures) out of the ordinary
course of business and consistent with past practices; (b) issue, reissue or sell, or authorize the issuance, reissuance or sale of shares of capital stock of any class, or securities convertible into capital stock of any class, or any rights,
warrants or options to acquire any convertible securities or capital stock; (c) dispose of any of assets or properties except to the extent these are used, retired or replaced in the ordinary course of business; (d) fail to keep in force
any Permits required by the Company or any of its Subsidiaries to carry on business as currently conducted; (e) fail to keep in force material Intellectual Property rights required by the Company or any of its Subsidiaries to carry on business
as currently conducted; (f) fail to perform all material obligations required to be performed by the Company or any of its Subsidiaries under any of the Material Contracts; (g) enter into transactions with Affiliates of the Company or any
of its Subsidiaries (other than in transactions related to the clearing of securities in the ordinary course of business, as disclosed in the SEC Documents or as set forth on Schedule 3.18); (h) pay any dividends to stockholders of
the Company (other than the one-time payment of the Company’s regular end-of-the-year dividend in the ordinary course of business in an amount not to exceed an aggregate of $30,000,000, including the amount of the Special Payment, if any);
(i) redeem the shares of stockholders of the Company other than pursuant to an existing restricted stock purchase agreement with current or former employees; (j) amend the Existing Certificate of Incorporation or the Existing Bylaws; or
(k) knowingly take any action or enter into any transaction which has, or would reasonably be expected to have, the effect of intentionally delaying or otherwise impeding the consummation of the transactions contemplated by this Agreement and
each of the other Transaction Documents. 
  
 8.2 Stockholder
Approval. 
  
 (a) As soon as practicable following the date
hereof, the Company will prepare and file the Proxy Statement with the Commission. The Company shall use its commercially reasonable efforts to (i) respond as promptly as practicable to any comments of the Commission with respect thereto,
(ii) have or cause the Proxy Statement to be cleared by the Commission as promptly as practicable and (iii) cause the Proxy Statement to be mailed to the Company’s stockholders as promptly as practicable thereafter. The Purchasers
shall furnish all information concerning the Purchasers or their Affiliates, including William E. Ford, as the Company may reasonably request and is required under applicable law in connection with the preparation of the Proxy Statement. The
information supplied by the Purchasers for inclusion in the Proxy Statement shall not, at the date the Proxy Statement is first mailed to stockholders of the Company and at the time of the meeting of the stockholders, as the case may be, contain any
untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. The Company shall promptly
notify each of the Purchasers upon the receipt of comments from the Commission or its staff or any request from the Commission or its staff for amendments or supplements to the Proxy Statement and shall provide each of the Purchasers with copies of
all correspondence 

  

 35 

 
between the Company and its representatives, on the one hand, and the Commission and its staff, on the other hand. Notwithstanding the foregoing, prior to
filing or mailing the Proxy Statement (or any amendment or supplement thereto) or responding to any comments of the Commission with respect thereto, the Company (x) shall provide each of the Purchasers with an opportunity to review and comment
on such document or response and (y) shall include in such document or response all comments reasonably proposed by the Purchasers. The Company shall use its commercially reasonable efforts to cause the Proxy Statement to comply in all material
respects with the applicable provisions of the Exchange Act and the rules and regulations promulgated thereunder, including without limitation, Section 14(a) thereof. 
  
 (b) Following the clearance by the Commission of the Proxy Statement and upon the mailing thereof to the Company’s
stockholders, the Company shall call and arrange for a special meeting of the stockholders of the Company to be held as promptly as permitted under the Exchange Act after such clearance (the “Stockholders’ Meeting”) and take
such other actions necessary to obtain the Stockholder Approval as promptly as practicable. The Company shall, through the Board of Directors recommend to the Company’s stockholders that they approve and authorize the Fundamental Actions. The
Company shall call, give notice of, convene and hold the Stockholders’ Meeting and submit the Fundamental Actions to a vote of the Company’s stockholders, regardless of the commencement, disclosure, announcement or submission to it of any
Alternative Proposal, any furnishing of information, discussions or negotiations with respect thereto of the type permitted by subsection (B) of the proviso to the first sentence of Section 8.3 or any change, modification, withdrawal or
other alteration of the Board of Directors’ recommendation with respect to the Fundamental Actions. Prior to the Stockholders’ Meeting, the Company shall not submit to the vote of its stockholders any Alternative Proposal or propose to do
so. 
  
 8.3 No Solicitation. Prior to the Closing, the
Company shall not, and shall cause its Subsidiaries and the officers, directors, employees, representatives (including, without limitation, investment bankers, attorneys and accountants), agents or Affiliates of the Company and its Subsidiaries not
to, directly or indirectly, (i) solicit, initiate, encourage or facilitate any inquiries or the making of the proposal or offer with respect to an Alternative Proposal or (ii) participate in any discussions or negotiations with, or provide
any non-public information to, or afford any access to the properties, books or records of the Company or any of its Subsidiaries, or otherwise take any other action to assist or facilitate (including granting any waiver or release under any
standstill or similar agreement with respect to any securities of the Company or any of its Subsidiaries), any “person” or “group” (as such terms are used for purposes of Section 13(d)(3) of the Exchange
Act) (other than the Purchasers or any Affiliate or associate of the Purchasers) concerning any Alternative Proposal; provided that, nothing contained in this Agreement shall prevent the Company or the Board of Directors from
(A) complying with Rule 14d-9 or 14e-2 promulgated under the Exchange Act with regard to an Alternative Proposal or (B) providing information (pursuant to a confidentiality agreement in reasonably customary form, which is no more
favorable than the Confidentiality Agreement and which does not contain terms that prevent the 

  

 36 

 
Company from complying with its obligations under this Section 8.3) to or engaging in any negotiations or discussions with any “person” or
“group” (as such terms are used for purposes of Section 13(d)(3) of the Exchange Act) who has made an unsolicited bona fide Alternative Proposal with respect to a Change of Control Transaction, if, with respect to the actions set
forth in clause (B), the Board of Directors, after consulting with and taking into account the advice of its outside legal counsel and its financial advisers, determines in good faith that (i) such Change of Control Transaction is reasonably
capable of being completed without undue delay taking into account all legal, financial, regulatory and other aspects of the proposal and the party making the proposal, (ii) any required financing to complete such Change of Control Transaction
has been demonstrated to the satisfaction of the Board of Directors of the Company, acting in good faith, will be timely obtained and (iii) taking such action is necessary in order for the Board of Directors to comply with its fiduciary
obligations under any Requirements of Law. Notwithstanding the proviso to the immediately preceding sentence, the Company shall remain obligated (i) to use its commercially reasonable efforts to consummate the transactions contemplated by this
Agreement (including the NYMEX Merger) as expeditiously as possible, and (ii) to submit the Fundamental Actions to the vote of the stockholders of the Company at the Stockholder’s Meeting as soon as practicable, in accordance with
Section 8.2. 
  
 8.4 Commercially Reasonable Efforts.
Subject to the terms and conditions herein provided, each of the parties hereto agrees to use its commercially reasonable efforts to take, or cause to be taken, all appropriate action, and to do, or cause to be done, all things necessary, proper or
advisable under applicable Requirements of Law (including all filings to be made with, and consents to be obtained from, the CFTC and the National Futures Association and all determinations or certifications to be made under the Commodities Laws) to
consummate and make effective, in the most expeditious manner practicable, the transactions contemplated by this Agreement. Without limiting the foregoing, each of the Company and the Purchasers shall use its commercially reasonable efforts to make
promptly any required submissions under any applicable Requirements of Law that the Company or the Purchasers determines is required to be made, in each case, with respect to the transactions contemplated hereby and to respond as promptly as
practicable to all inquiries received from any Governmental Authority with respect to such submissions for additional information or documentation. 
  
 8.5 HSR Act and CFTC Approval. The Company will promptly execute and file, or join in the execution and filing of, any application, notification
(including any notification or provision of information, if any, that may be required under the HSR Act, which the Company shall file no later than 10 Business Days after the date hereof) or other document that may be necessary in order to obtain
the authorization, approval or consent of any Governmental Authority, which may be reasonably required, or which the Purchasers may reasonably request, in connection with the consummation of the transactions contemplated by this Agreement. The
Company will use commercially reasonable efforts to obtain, or assist the Purchasers in obtaining, all such authorizations, approvals and consents, including without limitation using commercially reasonable 

  

 37 

 
efforts to supply as promptly as practicable any additional information and documentary material that may be requested pursuant to the HSR Act and to request
the expiration or termination of the applicable waiting periods under the HSR Act as soon as practicable. The Company shall, in connection with its obligation to use commercially reasonable efforts to obtain, or assist the Purchasers in obtaining,
all such requisite authorizations, approvals or consents, use commercially reasonable efforts to (i) cooperate in all reasonable respects with the Purchasers in connection with any filing or submission and in connection with any investigation
or other inquiry, including any proceeding initiated by a private party, (ii) promptly inform the Purchasers of any communication received by the Company from or given by the Company to, the United States Department of Justice (the
“DOJ”), the United States Federal Trade Commission (the “FTC”), the CFTC or any other Governmental Authority or quasi-governmental entity and of any material communication received or given in connection with any
proceeding by a private party, in each case regarding any of the transactions contemplated hereby, (iii) permit the Purchasers, or the Purchasers’ legal counsel, to review any communication given by it to, and consult with the Purchasers
in advance of any meeting or conference with, the DOJ, the FTC, the CFTC or any such other Governmental Authority or quasi-governmental entity or, in connection with any proceeding by a private party, with any other person and (iv) give the
Purchasers the opportunity to attend and participate in such meetings and conferences (other than with respect to the CFTC). 
  
 8.6 Tax Reporting. The Company shall not treat the Purchased Shares as “preferred stock” for purposes of the Code, including, but not
limited to, Section 305 thereof, except as required by any Requirements of Law or pursuant to a final determination. 
  
 8.7 Inspection. Prior to the Closing, the Company shall permit representatives of the Purchasers to visit and inspect any of its and its
Subsidiaries properties, to examine their corporate, financial and operating records and make copies thereof or abstracts therefrom, and to discuss their affairs, finances and accounts with their respective directors, officers and independent public
accountants, all at such reasonable times during normal business hours and as often as may be reasonably requested upon reasonable advance notice to the Company. Each Purchaser agrees that any information furnished by the Company relating to the
Company and its business may not be used for any purpose other than for evaluating and monitoring such Purchaser’s investment or future investment in the Company. Each Purchaser agrees to use, and to use its commercially reasonable efforts to
insure that its authorized representatives use, the same degree of care as such Purchaser uses to protect its own confidential information, to keep confidential any information furnished to it (so long as such information is not in the public
domain), except that such Purchaser may disclose such proprietary or confidential information (i) to any investor, Subsidiary, member or parent of such Purchaser for the purpose of evaluating its investment in the Company as long as such
investor, Subsidiary, member or parent of such Purchaser is subject to a customary confidentiality arrangement with such Purchaser, (ii) to the extent required by law, rule, regulation or legal process, provided that such Purchaser will use
reasonable efforts to notify the Company in advance of such disclosure so as to permit the Company to seek a 

  

 38 

 
protective order or otherwise contest such disclosure, and such Purchaser will use reasonable efforts to cooperate, at the expense of the Company, in
pursuing any such protective order, (iii) to the extent such information relating to the Company’s or any of its Subsidiaries’ business is or becomes publicly available other than as a result of a breach of this Section 8.7, or
(iv) to the extent the Company shall have consented to such disclosure. 
  
 8.8 Litigation. The Company shall notify the Purchasers in writing promptly after learning of any material action, proceeding, claim or investigation by or before any court, arbitrator or administrative agency,
initiated against it or any of its Subsidiaries, or, to the Knowledge of the Company, threatened against it or any of its Subsidiaries relating to the transactions contemplated by this Agreement. 
  
 8.9 IRS Forms. The Purchasers hereby covenant and agree with the
Company that on the date hereof, each of the Purchasers shall provide the Company, in the manner prescribed by applicable law, validly completed and executed Internal Revenue Service Forms W-9, W-8BEN, W8IMY, or other applicable form, certificate,
or document prescribed by the Internal Revenue Service for purposes of establishing such Purchaser’s status and entitlement to any reduction or exemption from U.S. withholding taxes (each an “IRS Form”); provided
that, the Company shall not withhold from any payments any amounts for taxes except as it reasonably believes is required, after consultation with the Purchasers, to be withheld under applicable Requirements of Law. After the Closing Date,
each Purchaser shall deliver such additional applicable IRS Forms as may then be required when a lapse in time or change of circumstance renders the previous IRS Form obsolete or inaccurate. 
  
 8.10 Intellectual Property. The Company shall use its commercially
reasonable efforts to (i) require that current employees of the Company or any Subsidiary involved in the creation of Intellectual Property for the Company or a Subsidiary, as determined in the commercially reasonable business judgment of the
Company, enter into agreements that provide that such employees are obligated to keep confidential proprietary information of, and assign Intellectual Property, including, without limitation, inventions, made by such employees during the course of
employment to, the Company or its Subsidiaries and (ii) institute a procedure, as determined in the commercially reasonable business judgment of the Company, intended to ensure that future employees of the Company or any Subsidiary enter into
such agreements. 
  
 ARTICLE IX 
  
 TERMINATION 
  
 9.1 Termination. This Agreement may be terminated prior to the Closing
as follows: 
  
 (a) at any time on or prior to
the Closing Date, by mutual written consent of the Company and the Purchasers; 
  

 39 

 (b) at the election of the Company or the Purchasers by written notice to the other parties hereto after
5:00 p.m., New York time, on March 31, 2006, if the Closing shall not have occurred, unless such date is extended by the mutual written consent of the Company and the Purchasers; provided, however, that the right to
terminate this Agreement under this Section 9.1(b) shall not be available (i) to any party whose breach of any representation, warranty, covenant or agreement under this Agreement has been the cause of, or resulted in, the failure of the
Closing to occur on or before such date or (ii) if the Closing has not occurred solely because either (x) any party hereto has not yet obtained any necessary approval from any Governmental Authority or the CFTC or (y) the Proxy
Statement is not cleared for mailing by the Commission to the Company’s stockholders by January 15, 2006 in which case such election may be made after 5:00 pm, New York time, on May 15, 2006; 
  
 (c) at the election of the Company, if there has been a material breach of
any representation, warranty, covenant or agreement on the part of any of the Purchasers contained in this Agreement, which breach has not been cured within fifteen (15) Business Days of notice to the Purchasers of such breach; 
  
 (d) at the election of the Purchasers, if there has been a material breach
of any representation, warranty, covenant or agreement on the part of the Company contained in this Agreement, which breach has not been cured within fifteen (15) Business Days notice to the Company of such breach; or 
  
 (e) at the election of the Company or the Purchasers, if Stockholder
Approval shall not have been obtained at the Stockholders’ Meeting (including adjournments and postponements) duly convened in accordance with Section 8.2(b). 
  
 If this Agreement so terminates, it shall become null and void and have no further force or effect, except as provided in
Section 9.2. 
  
 9.2 Survival. If this Agreement is
terminated and the transactions contemplated hereby are not consummated as described above, this Agreement shall become void and of no further force and effect, except for the provisions of Article I, this Section 9.2 and
Sections 10.2 through 10.4 (inclusive); provided, however, that (a) none of the parties hereto shall have any liability in respect of a termination of this Agreement pursuant to Section 9.1(a), Section 9.1(b) or
Section 9.1(e), (b) nothing shall relieve any of the parties from liability for actual damages resulting from a breach of the covenants set forth in Sections 8.2 and 8.3 or a willful breach of any other representation, warranty,
covenant or agreement which gave rise to a termination of this Agreement pursuant to Section 9.1(c) or 9.1(d); and provided, further, that none of the parties hereto shall have any liability for speculative, unforeseeable,
punitive, exemplary or consequential damages or lost profits resulting from any legal action relating to any termination of this Agreement. 
  

 40 

 ARTICLE X 
  
 MISCELLANEOUS 
  
 10.1 Survival of Representations, Warranties and Covenants. All of the representations and warranties made herein shall survive the execution and
delivery of this Agreement until the date that is thirty (30) days after the receipt by the Purchasers of audited financial statements of the Company for the fiscal year ending December 31, 2006 (or, if such fiscal year changes and no such
audited consolidated financial statements are available, then the successor fiscal year), except for the second sentence of Section 3.1, Section 3.2, Section 3.4, Section 3.7, Section 3.12, Section 4.5, Section 4.6
and Section 4.8, which representations and warranties shall survive until the third anniversary of the Closing Date. The covenants (other than Sections 8.6 and 8.9) shall survive the Closing in accordance with their terms and for
90 days thereafter. For purposes of this Section 10.1, “receipt by the Purchasers of audited financial statements of the Company” shall be deemed to occur no earlier than the second day following their public availability on the
Commission’s EDGAR website. 
  
 10.2 Notices. All
notices, demands and other communications provided for or permitted hereunder shall be made in writing and shall be by registered or certified first-class mail, return receipt requested, telecopier, courier service or personal delivery: 

 
 (a) if to the Company: 
  
 NYMEX Holdings, Inc. 
 One North End Avenue 
 World Financial
Center 
 New York, New York 10282-1101 
 Telecopier: (212) 301-4568 
 Attention: Office of the Chairman 
  
 with a copy to the General Counsel at the same address as 
 above and with the following facsimile number: 
  
 Telecopier: (212) 299-2299 
 Attention:
General Counsel 
  
 with a copy (which shall not constitute
notice) to: 
  
 Skadden, Arps, Slate, Meagher & Flom
LLP 
 Four Times Square 
 New York, New York 10036-6518 
 Telecopier: (917) 777-2204 
 Attention: Eric J. Friedman, Esq. 
  

 41 

 (b) if to any of the Purchasers: 
  
 c/o General Atlantic Service Corporation 
 3 Pickwick Plaza 
 Greenwich, Connecticut
06830 
 Telecopier: (203) 622-8818 
 Attention: William E. Ford 
                   David A. Rosenstein, Esq. 
  
 with a copy (which shall not constitute notice) to: 
  
 Paul, Weiss, Rifkind, Wharton & Garrison LLP 
 1285 Avenue of the Americas 
 New York, New York 10019-6064 
 Telecopier: (212) 757-3990 
 Attention:
Douglas A. Cifu, Esq. 
  
 All such notices, demands and other
communications shall be deemed to have been duly given when delivered by hand, if personally delivered; when delivered by courier, if delivered by commercial courier service; five (5) Business Days after being deposited in the mail, postage
prepaid, if mailed; and when receipt is mechanically acknowledged, if telecopied. Any party may by notice given in accordance with this Section 10.2 designate another address or Person for receipt of notices hereunder. 
  
 10.3 Successors and Assigns; Third Party Beneficiaries. This Agreement
shall inure to the benefit of and be binding upon the successors and permitted assigns of the parties hereto. Subject to applicable securities laws and the terms and conditions of the other Transaction Documents, the Purchasers may assign any of
their rights under the other Transaction Documents to any of their respective Affiliates. The Company may not assign any of its rights under this Agreement without the written consent of the Purchasers, other than pursuant to the NYMEX Merger.
Except as provided in Article VII, no Person other than the parties hereto and their successors and permitted assigns is intended to be a beneficiary of this Agreement. 
  
 10.4 Amendment and Waiver. 
  

(a) No failure or delay on the part of the Company or the Purchasers in exercising any right, power or remedy hereunder shall operate as a waiver
thereof, nor shall any single or partial exercise of any such right, power or remedy preclude any other or further exercise thereof or the exercise of any other right, power or remedy. 
  
 (b) Any amendment, supplement or modification of or to any provision of this Agreement, any waiver of any provision of this
Agreement, and any consent to any departure by the Company or the Purchasers from the terms of any provision of this Agreement, shall be effective (i) only if it is made or given in writing and signed by the Company and each of the Purchasers
and (ii) only in the specific 

  

 42 

 
instance and for the specific purpose for which made or given. Except where notice is specifically required by this Agreement, no notice to or demand on the
Company or the Purchasers in any case shall entitle the Company or the Purchasers, respectively, to any other or further notice or demand in similar or other circumstances. 
  
 10.5 Counterparts. This Agreement may be executed in any number of counterparts and by the parties hereto in separate
counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. 
  
 10.6 Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.

  
 10.7 Specific Performance. The parties to this
Agreement agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. Accordingly, the parties to this Agreement hereby
agree that each party hereto shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in any court of the United States or any state having
jurisdiction, in addition to any other remedy to which such party may be entitled at law or in equity. 
  
 10.8 GOVERNING LAW; CONSENT TO EXCLUSIVE JURISDICTION. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF
THE STATE OF NEW YORK, WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW THEREOF. The parties hereto irrevocably submit to the exclusive jurisdiction of any state or federal court sitting in the County of New York, in the State of
New York over any suit, action or proceeding arising out of or relating to this Agreement. To the fullest extent they may effectively do so under applicable law, the parties hereto irrevocably waive and agree not to assert, by way of motion, as
a defense or otherwise, any claim that they are not subject to the jurisdiction of any such court, any objection that they may now or hereafter have to the laying of the venue of any such suit, action or proceeding brought in any such court and any
claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. 
  
 10.9 WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A
TRIAL BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH OF THE PARTIES HERETO HEREBY (A) CERTIFIES THAT NO
REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO
ENTER INTO 

  

 43 

 
THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS
SECTION 10.9. 
  
 10.10 Severability. If any one or more of
the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable in any respect for any reason, the validity, legality and enforceability of any such provision in every other respect and of
the remaining provisions hereof shall not be in any way impaired, unless the provisions held invalid, illegal or unenforceable shall substantially impair the benefits of the remaining provisions hereof. 
  
 10.11 Rules of Construction. Unless the context otherwise requires,
references to sections or subsections refer to sections or subsections of this Agreement. 
  
 10.12 Entire Agreement. This Agreement, together with the exhibits and schedules hereto, and the other Transaction Documents are intended by the parties as a final expression of their agreement and intended to
be a complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein and therein. There are no restrictions, promises, representations, warranties or undertakings, other
than those set forth or referred to herein or therein. This Agreement, together with the exhibits and schedules hereto, and the other Transaction Documents supersede all prior agreements and understandings between the parties with respect to such
subject matter, including, without limitation, those certain Terms of Preferred Stock Purchase by GA LLC entered into on September 20, 2005. 
  
 10.13 Fees. If the Closing occurs, then the Company shall reimburse the Purchasers for all of their reasonable fees, disbursements and other
charges of counsel reasonably incurred in connection with the transactions contemplated by this Agreement up to an aggregate amount of $250,000. 
  
 10.14 Publicity; Confidentiality. Except as may be required by applicable Requirements of Law, none of the parties hereto shall issue a press
release or public announcement or otherwise make any disclosure concerning this Agreement or the transactions contemplated hereby, without prior written approval by the other parties hereto; provided, however, that nothing in this
Agreement shall restrict the parties from disclosing information (a) that is already publicly available, (b) that was known to the parties on a non-confidential basis prior to its disclosure by another party, (c) that may be required
or appropriate in response to any summons or subpoena or in connection with any litigation, provided that the parties will use reasonable efforts to notify the other parties in advance of such disclosure so as to permit the other
parties to seek a protective order or otherwise contest such disclosure, and the parties will use reasonable efforts to cooperate, at the expense of such party contesting disclosure, in pursuing any such protective order, (d) in order to comply
with any Requirement of Law, (e) to the Purchasers’ or the Company’s officers, directors, stockholders, members, partners, investors, advisors, employees, controlling persons, auditors or counsel or (f) to Persons from whom
releases, consents or approvals are required, or to whom notice is required to be provided, pursuant to any Requirement of Law; and provided further, that from and 

  

 44 

 
after Closing, GA LLC may disclose on its worldwide web page, www.generalatlantic.com, the name of the Company, the name of the Chief Executive Officer of
the Company, a brief description of the business of the Company and the Company’s logo and the aggregate amount of the Purchasers’ investment in the Company. If any announcement is required by any Requirement of Law to be made by any party
hereto, prior to making such announcement such party will deliver a draft of such announcement to the other parties and shall give the other parties reasonable opportunity to comment thereon. If the Company wishes to issue any press release or
public comment or otherwise make any disclosure concerning the Purchasers that is not required by a Requirement of Law, other than a brief description of GA LLC or the Purchasers and GA LLC’s logo and the aggregate amount of the
Purchasers’ investment in the Company, the Company shall first consult with the Purchasers and give them a reasonable opportunity to comment thereon prior to issuing any such press release, public comment or other disclosure, or if applicable,
comply with Section 10.14(c). 
  
 10.15 Further
Assurances. Each of the parties shall execute such documents and perform such further acts (including, without limitation, obtaining any consents, exemptions, authorizations or other actions by, or giving any notices to, or making any filings
with, any Governmental Authority or any other Person) as may be reasonably required or desirable to carry out or to perform the provisions of this Agreement. 
  
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 
  

 45 

 IN WITNESS WHEREOF, the undersigned have executed, or have caused to be executed, this Stock Purchase
Agreement on the date first written above. 
  

			
	 NYMEX HOLDINGS, INC.

		
	 By:
	 	/s/ Mitchell Steinhause
	 Name:
	 	Mitchell Steinhause
	 Title:
	 	Chairman and Principal Executive Officer

  

			
	 GENERAL ATLANTIC PARTNERS 82, L.P.

		
	 By:
	 	 GENERAL ATLANTIC LLC, 
         its General Partner

		
	 By:
	 	/s/ William E. Ford
	 Name:
	 	William E. Ford
	 Title:
	 	President and Managing Director

  

			
	 GAPSTAR, LLC

		
	 By:
	 	 GENERAL ATLANTIC LLC, 
         its Sole Member

		
	 By:
	 	/s/ William E. Ford
	 Name:
	 	William E. Ford
	 Title:
	 	President and Managing Director

  

			
	 GAP COINVESTMENTS III, LLC

		
	 By:
	 	/s/ William E. Ford
	 Name:
	 	William E. Ford
	 Title:
	 	A Managing Member

  

			
	 GAP COINVESTMENTS IV, LLC

		
	 By:
	 	/s/ William E. Ford
	 Name:
	 	William E. Ford
	 Title:
	 	A Managing Member

			
	 GAPCO GMBH & CO. KG

		
	 By:
	 	 GAPCO MANAGEMENT GMBH, 
         its General Partner

		
	 By:
	 	/s/ Matthew Nimetz
	 Name:
	 	 Matthew Nimetz

	 Title:
	 	 Managing Director2006 Stock Option Plan for Non-Employee Directors

 Exhibit 4.1 
  
 RICHARDSON ELECTRONICS, LTD. 
 2006
STOCK OPTION PLAN FOR NON-EMPLOYEE DIRECTORS 
  
 Article I

 Purpose 
  
 The purpose of the 2006 Stock Option Plan for Non-Employee Directors (the “Plan”) of Richardson Electronics, Ltd. (the “Company”) is
to promote the long-term interests of the Company by attracting and retaining qualified and experienced persons for service as non-employee directors of the Company and by providing additional incentive for such directors to work for the success and
growth of the Company. 
  
 Article II 
 Definitions 
  
 When used herein, the following terms shall have the meaning set forth below: 
  
 2.1 “Board” means the Board of Directors of the Company. 
  
 2.2 “Change in Control” means the earliest of: 
  
 (a) The acquisition after August 1, 1989 of beneficial ownership, as
that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended, by any entity, person, or group, of shares of the outstanding capital stock of the Company entitled to vote for the election of directors (“voting
stock”) representing more than 50% of the aggregate votes entitled to be cast in the election of directors; 
  
 (b) The commencement by any entity, person, or group (other than the Company or a Subsidiary or Edward J. Richardson) of a tender offer or an exchange
offer for shares of the outstanding voting stock of the Company representing more than 50% of the aggregate votes entitled to be cast in the election of directors. 
  
 (c) The effective time of (i) a merger or consolidation of the Company with one or more other corporations as a result
of which the holders of the outstanding voting stock of the Company immediately prior to such merger or consolidation (other than those who are affiliates of any such other corporation) hold less than 50% of the voting stock of the surviving or
resulting corporation, or (ii) a transfer of substantially all of the property of the Company other than to an entity of which the Company owns at least 50% of the voting stock; or 
  
 (d) The election to the Board, without the recommendation or approval of the incumbent Board, of the lesser of
(i) three directors or (ii) directors constituting a majority of the number of directors of the Company then in office. 
  
 2.3 “Code” means the Internal Revenue Code of 1986, as amended, in effect at the time of reference, or any successor revenue code which may
hereafter be adopted in lieu thereof, and references to the specific provisions of the Code shall refer to the corresponding provisions of the Code as it may hereafter be amended or replaced. 
  
 2.4 “Company” means Richardson Electronics, Ltd., a Delaware
corporation, or its successor. 
  
 2.5 “Disability”
means the disability of an individual within the meaning of Section 105(d)(4) of the Code. 
  
 2.6 “Fair Market Value” means, with respect to the Company’s Shares, the last sale price of the Shares on the date on which the value is to
be determined, as reported by NASDAQ National Market System or such other source of quotations for or reports of trading activity in Shares as the Board may from time to time select. If no trades in Shares occurred on the relevant date, the mean
between the closing bid and asked quotations for Shares as reflected by NASDAQ National Market System or such other source of quotations at the close of the market on such date shall be deemed to be the fair market value; provided, however, that if
no sales or quotations are reported on the relevant date, then Fair Market Value determined as provided above on the next succeeding day or which a sale or quotation is reported shall be deemed to be the fair market value on the relevant date.

  
 2.7 “Non-Employee Director” means a director of the
Company who is not an officer or employee of the Company or any of its Subsidiaries. A “Non-Employee Director” may include any director of the Company who also serves as a consultant to the Company or any of its Subsidiaries. 

 
 2.8 “Non-Qualified Stock Option” means an option not entitled to
special tax treatment under Section 422 of the Code. 

 2.9 “Option” means an option to purchase Shares granted under this Plan whether under 6.2 or
6.3. “First Option” means an Option granted under 6.2 and “Additional Option” means an Option granted under 6.3. 
  
 2.10 “Optionee” means a person to whom an Option is granted. 
  
 2.11 “Plan” means the Company’s 2006 Stock Option Plan for Non-Employee Directors contained herein, and as it
may be amended from time to time. 
  
 2.12 “Retirement”
means the voluntary retirement of a Non-Employee Director of the Company at or after age 70 with not less than ten (10) consecutive years of service as a director of the Company or with approval of the Board. 
  
 2.13 “Shares” means the shares of the Company’s Common Stock
$.05 par value. 
  
 2.14 “Subsidiary” means any
corporation that at the time qualifies as a subsidiary of the Company under the definition of “subsidiary corporation” contained in Section 424(f) of the Code. 
  
 Article III 
 Administration of the Plan 
  
 The Plan shall be
administered by the Board. The Board shall have the sole responsibility for construing and interpreting the Plan, for establishing and amending such rules and regulations as it deems necessary or desirable for the proper administration of the Plan,
and for resolving all questions arising under the Plan. 
  
 Any
decision or action taken by the Board arising out of or in connection with the construction, administration, interpretation and effect of the Plan and of its rules and regulations shall, to the extent permitted by law, be within its absolute
discretion, except as otherwise specifically provided herein, and shall be conclusive and binding upon all Optionees and any other person, whether that person is claiming under or through any Optionee or otherwise. No member of the Board shall be
liable for any action taken or determination made in good faith with respect to the Plan. 
  
 Article IV 
 Eligibility 
  
 All Non-Employee Directors of the Company shall be eligible to participate in the Plan. 
  
 Article V 
 Shares Subject to the Plan 
  
 The total number of Shares which are available for granting options under the Plan shall be 400,000 (subject to adjustment as provided in this Section 5 and in Section 12) and such number of Shares are
reserved for issuance upon the exercise of Options. The Shares issued upon exercise of an Option shall be made available, in the discretion of the Board, either from authorized but unissued Shares or from any outstanding Shares which have been
reacquired by the Company. In the event that any Option terminates for any reason, without having been exercised in full, the unpurchased Shares subject to that Option shall once again become available for the granting of Options. 
  
 Article VI 
 Granting of Options 
  
 6.1 All grants of Options under the Plan shall be automatic and non-discretionary, and subject to the terms and conditions provided in this Section 6 and elsewhere in the Plan. All Options granted under the Plan
shall be Non-Qualified Stock Options. 
  
 6.2 Subject to the
provisions of the Plan, each Non-Employee Director who is elected or appointed to the Board for the first time after on or after October 18, 2005 shall be granted a First Option to purchase 25,000 Shares (subject to adjustment as provided in
Section 12) on the date such director first takes office. 
  
 6.3 Subject to the provisions of the Plan, each Non-Employee Director who is in office on each October 30 hereafter which is on or after the fifth anniversary or his or her election as a director of the Company shall, on each such
October 30, shall be granted an Additional Option to purchase 5,000 Shares (subject to adjustment as provided in Section 12). 
  
 6.4 The purchase price of each Share that may be purchased upon exercise of an Option shall be the Fair Market Value of the Share on the date the Option
is granted. 
  
 6.5 Each First Option shall vest and be
exercisable over a five (5) year period from its 

 
respective date of grant. Twenty percent (20%) of the total Shares covered by the First Option shall become exercisable on the first anniversary of the
date of grant of the First Option and an additional twenty percent (20%) shall become exercisable on each subsequent anniversary of the date of grant of the First Option. 
  
 6.6 Each Additional Option shall be fully vested and exercisable on the later of the date of approval of this Plan by the
stockholders of the Company or its grant date. 
  
 Article VII

 Termination of Directorship 
  
 7.1 The Option of any Optionee whose status as a director of the Company shall terminate because of death or Disability may be exercised, to the extent
exercisable on the date of death or Disability, at any time within one year after the date of such termination or prior to the date on which the Option expires by its terms, whichever is earlier. Any such exercise shall be made (i) in the case
of the death of the Optionee, by the executor or administrator of the estate of the deceased Optionee or person or persons to whom the deceased Optionee’s rights under the option shall pass by will or by the laws of descent and distribution,
and (ii) in the case of the Disability of the Optionee, by the Optionee or by the Optionee’s guardian or legal representative. 
  
 7.2 The Option of any Optionee whose status as a director shall terminate because of Retirement, or removal from the Board within one year after a Change
of Control, shall become fully exercisable with respect to all Shares covered thereby and not previously purchased upon exercise of the Option, and shall remain fully exercisable until the Option expires by its terms. 
  
 7.3 The Option of any Optionee whose status as a director shall terminate for
any reason other than as specified in Sections 7.1 and 7.2 herein may be exercised, to the extent exercisable on the date of such termination, within three months after the date of such termination or prior to the date on which the Option expires by
its terms, whichever is earlier. 
  
 7.4 In the event of the death
or Disability of an Optionee during the period after a termination of his directorship but prior to the expiration of the right to exercise the Option in a situation governed by Section 7.2 or 7.3, or in the event of an Optionee’s death
after becoming Disabled but prior to the expiration of the right to exercise the Option in a situation governed by Section 7.1, then in such event, (i) in the case of death of the Optionee the executor or administrator of the estate of the
deceased Optionee, or person or persons to whom the Optionee’s rights under the Option shall pass by will or the laws of descent and distribution, and (ii) in the case of Disability of the Optionee, by Optionee or the Optionee’s legal
guardian or legal representative, shall have the right to exercise the Option before the date that the right to exercise the Option would otherwise have expired, but only as to the number of Shares as to which such Option was exercisable on the date
of death or Disability. 
  
 In any such event, unless so exercised
within the period as aforesaid the Option shall terminate at the expiration of the said period. 
  
 Article VIII 
 Non-Transferability of Options 
  
 Each Option granted under the Plan shall not be transferable otherwise than
by will or by the laws of descent and distribution, and shall be exercised during the lifetime of the Optionee only by the Optionee or by the Optionee’s guardian or legal representative. 
  
 Article IX 
 Terms of Options 
  
 Options shall expire ten (10) years and one month from the date of the granting thereof, but shall be subject to earlier termination as provided in Section 7. Options shall be evidenced by written agreements
containing such terms and conditions, consistent with the provisions of this Plan. Each agreement shall comply with and shall be subject to the terms and conditions of the Plan and shall conclusively evidence, by the Non-Employee Director’s
signature thereon, that it is the intent of the Non-Employee Director to continue to serve as a director of the Company for the remainder of his or her term during which the Option was granted. 

 Article X 
 Exercise of Options 
  
 An
Option may be exercised by delivery of a written notice signed by the person (or persons) exercising the Option (and in the event the Option is being exercised by any person other than the Optionee, shall be accompanied by proof, satisfactory to
counsel for the Company, of the rights of such person to exercise the Option), specifying the number of Shares with respect to which the Option is being exercised, and shall be accompanied by payment in full of the purchase price of any Shares to be
purchased, in the form of either (i) a cashier’s or certified check, (ii) in the discretion of the Board, the tender to the Company of Shares already owned by the Optionee for a period of at least six months as of the date of tender
having a Fair Market Value equal to the purchase price, or (iii) in the discretion of the Board, a combination of the forms described in (i) and (ii). No Shares shall be issued upon exercise of an Option until full payment has been made
therefor. Shares issued upon exercise of an Option shall be issued only in the name of the Optionee or in the event of his or her death his or her estate or the person or persons to whom the Optionee’s rights pass. The date of exercise of an
Option shall be the date the Notice shall have been delivered to the Secretary of the Company together with payment of the exercise price for the Shares being purchased, but the exercise of an Option shall not be effective until the person (or
persons) exercising the Option shall have complied with all the provisions of the Option Agreement governing the exercise of the Option and with all applicable securities, tax and other laws. The Company shall deliver certificates for the Shares for
which the Option is exercised as soon as practicable after receipt of the Notice and the Payment. An Option may not be exercised for fewer than one hundred (100) Shares at any one time unless the number purchased is the total number of Shares
for which the Option may be exercised at that time. The Company may make appropriate arrangements with a broker or other institution to receive sale or loan proceeds in the amount of the exercise price upon delivery of an irrevocable exercise notice
and instructions to promptly deliver the sale or loan proceeds in the amount of the exercise price or similar arrangements satisfactory to the Company. The delivery of such notice and instructions or compliance with similar arrangements approved by
the Company shall be deemed conditional payment of the purchase price authorizing delivery of the shares by the Company 
  
 Article XI 
 Listing and Registration
of Shares; Contracts 
  
 The obligation of the Company to sell
and deliver the Shares pursuant to the exercise of Options granted under this Plan shall be subject to all applicable laws, regulations, rules and approvals. 
  
 Each Option shall be subject to the requirement that, if at any time the Board shall determine, in its discretion, that the listing, registration or
qualification of the Shares covered thereby upon any securities exchange or under any state or federal law, or the consent or approval of any governmental regulatory body, is necessary or desirable as a condition of, or in connection with, the
granting of such Option or the issuance or purchase of Shares thereunder, such Option may not be exercised in whole or in part unless and until such listing, registration, qualification, consent or approval shall have been effected or obtained free
of any conditions not acceptable to the Board. Notwithstanding the foregoing, the Company shall have no obligation to cause any Shares to be registered or qualified under any federal or state law or listed on any stock exchange or admitted to any
national market system or included in any interdealer quotation system. Each Option shall also be subject to the condition that the Company shall not be obligated to issue or transfer its Shares to the Optionee thereof on its exercise, if the Board
determines that such issuance or transfer would violate any covenant in any loan agreement or other contract to which the Company is a party. 
  
 Article XII 
 Adjustment for Changes
in Capitalization 
  
 12.1 If there is any change in the
number of Shares through the declaration of stock dividends or through a recapitalization which results in stock splits or reverse stock splits, the Board shall make corresponding adjustments to the number of Shares available for Options, the number
of Shares covered by Options to be granted, the number of Shares covered by outstanding Options, and the price per Share of such outstanding Options in order to appropriately reflect any increase or decrease in the number of issued Shares; provided,
however, that any fractional Shares resulting from such adjustment shall be eliminated. Any determination made by the Board relating to such adjustments shall be final, binding, and conclusive. 
  
 12.2 In the event of a change in the Shares, as constituted as of the date of
this Plan, which is limited to a change of all of its authorized Shares with par value into the same number of shares of Common Stock with a different par value or without par value, the shares of Common Stock resulting from any such change shall be
deemed to be the Shares within the meaning of the Plan. 

 12.3 If changes in capitalization other than those considered above shall occur, the Board may make such
adjustment in the number of class of shares as to which Options may thereafter be granted, and in the number and class of shares remaining subject to Options then outstanding and the price per Share of such Options as the Board in its discretion may
consider appropriate, and all such adjustments, if any, shall be conclusive upon all persons. 
  
 12.4 Except as hereinbefore expressly provided in this Section 12, an Optionee shall have no rights by reason of any subdivision or consolidation of shares of stock of any class or the payment of any stock
dividend or any other increase or decrease in the number of shares of stock of any class or by reason of any dissolution, liquidation, merger, or consolidation or spin-off of assets or stock of another corporation, and any issue by the Company of
shares of stock of any class, or securities convertible into shares of stock of any class, shall not affect, and no adjustment by reason thereof shall be made with respect to the number or price of Shares subject to the Option. The grant of an
Option shall not affect in any way the right or power of the Company to make adjustments, reclassifications, reorganizations or changes of its capital or business structures or to merge or to consolidate or to dissolve, liquidate or sell or transfer
all or part of its business or assets. 
  
 Article XIII

 Taxes 
  
 The Company shall make such provisions in the written option agreements as it shall deem necessary or desirable to pay or withhold the amount of any tax
attributable to any amounts payable under any option. 
  
 Article XIV 
 Limitation of Rights 
  
 14.1 Neither the Plan, nor the granting of an Option nor any other action taken pursuant to the Plan, shall constitute or be
evidence of any agreement or understanding, express or implied, that the Company will retain a director for any period of time, or at any particular rate of compensation. 
  
 14.2 An Optionee shall have no rights as a stockholder with respect to the Shares covered by options until the date of the
issuance of a stock certificate upon exercise thereof, and no provision will be made for dividends or other rights for which the record date is prior to the date such stock certificate is issued. 
  
 Article XV 
 Other Actions 
  
 Nothing in the Plan shall be construed to limit the authority of the Company to exercise its corporate rights and powers, including, by way of illustration and not by way of limitation, the right to grant options for
proper corporate purposes otherwise than under the Plan to any employee or any other person, firm, corporation, association or other entity, or to grant options to, or assume options of, any person in connection with the acquisition, by purchase,
lease, merger, consolidation or otherwise, of all or any part of the business and assets of any person, firm, corporation, association or other entity. 
  
 Article XVI 
 Effective Date of the
Plan 
  
 The Plan shall become effective on October 18,
2005, subject to approval by the Company’s stockholders at the 2005 Annual Meeting of Stockholders or any adjournment thereof or at a Special Meeting of Stockholders. Options granted hereunder shall not be exercisable prior to such stockholder
approval. Unless earlier terminated by the Board, the Plan shall terminate on October 30, 2015. No Option shall be granted under the Plan after such date. Termination of the Plan, however, shall not affect the rights of Optionees under Options
previously granted to them, and all unexpired Options shall continue in force and operation after termination of the Plan until they lapse, expire or terminate as provided herein. 

 Article XVII 
 Termination and Amendment of the Plan 
  
 The Board may at any time terminate, suspend or amend the Plan, except that the Board shall not, without the approval of the Company’s stockholders, effect any change (other than through adjustment for changes as
provided in Section 12 above or except to conform the Plan and the offerings thereunder to changes in the Code or governing law) which: 
  

	 	17.1	increases the aggregate number of Shares for which Options may be granted; 

  

	 	17.2	materially modifies the requirements as to eligibility for participation in the Plan; 

  

	 	17.3	lengthens the maximum period during which an Option may be exercised; or 

  

	 	17.4	extends the period of time during which Options may be granted. 

  

	 	17.5	reduces the purchase price of Shares from that provided in 6.3 above. 

  
 No termination or amendment of the Plan shall adversely affect any right acquired by any Optionee under an option granted before the date of such
termination or amendment, unless such Optionee shall consent; but it shall be conclusively presumed that any adjustment for changes as provided in Section 12 above does not adversely affect any such right. 
  
 Article XVIII 
 Application of Funds 
  
 Any proceeds received by the Company as a result of the exercise of Options granted under the Plan may be used for any valid corporate purpose.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00093-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00093-of-00352.parquet"}]]